
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-01-19 05:29:30 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='loss', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/phrase_4_0.5_tag_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.5, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[8e-06], lr_scheduler='inverse_sqrt', max_epoch=50, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=4096, max_tokens_valid=4096, max_update=0, maximize_best_checkpoint_metric=False, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='../checkpoints/EMEA_p_6', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=1e-07)
2021-01-19 05:29:30 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-01-19 05:29:30 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-01-19 05:29:30 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.de
2021-01-19 05:29:30 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.en
2021-01-19 05:29:30 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA valid de-en 151 examples
2021-01-19 05:29:35 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-01-19 05:29:35 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-01-19 05:29:35 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-01-19 05:29:42 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-01-19 05:29:42 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-19 05:29:42 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-01-19 05:29:42 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-19 05:29:42 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-01-19 05:29:42 | INFO | fairseq_cli.train | max tokens per GPU = 4096 and max sentences per GPU = None
2021-01-19 05:29:51 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-01-19 05:29:51 | INFO | fairseq.trainer | loading train data for epoch 1
2021-01-19 05:29:51 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.de
2021-01-19 05:29:51 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.en
2021-01-19 05:29:51 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA train de-en 93981 examples
2021-01-19 05:29:52 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-19 05:29:54 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-01-19 05:29:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-01-19 05:29:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-01-19 05:29:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-01-19 05:29:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 4.0
2021-01-19 05:29:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 2.0
2021-01-19 05:30:15 | INFO | train_inner | epoch 001:    106 / 324 loss=6.293, nll_loss=4.96, ppl=31.12, wps=19946.6, ups=5.19, wpb=3836.9, bsz=288.7, num_updates=100, lr=2e-07, gnorm=37.94, loss_scale=2, train_wall=19, wall=32
2021-01-19 05:30:34 | INFO | train_inner | epoch 001:    206 / 324 loss=5.248, nll_loss=3.771, ppl=13.66, wps=19858.2, ups=5.16, wpb=3847.8, bsz=286.2, num_updates=200, lr=4e-07, gnorm=24.962, loss_scale=2, train_wall=19, wall=52
2021-01-19 05:30:38 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 1.0
2021-01-19 05:30:53 | INFO | train_inner | epoch 001:    307 / 324 loss=4.151, nll_loss=2.513, ppl=5.71, wps=19753.1, ups=5.16, wpb=3829.2, bsz=294.9, num_updates=300, lr=6e-07, gnorm=14.703, loss_scale=1, train_wall=19, wall=71
2021-01-19 05:30:57 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:30:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:30:58 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:30:59 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:30:59 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:31:00 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:31:00 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:31:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). In the studies, actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well the blood sugar is regulated. What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:31:03 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:31:03 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.971 | nll_loss 2.248 | ppl 4.75 | bleu 31.51 | wps 748.7 | wpb 1083 | bsz 37.8 | num_updates 317
2021-01-19 05:31:03 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:31:20 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_best.pt (epoch 1 @ 317 updates, score 3.971) (writing took 17.1393200927414 seconds)
2021-01-19 05:31:20 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-01-19 05:31:20 | INFO | train | epoch 001 | loss 5.162 | nll_loss 3.669 | ppl 12.72 | wps 14362.6 | ups 3.74 | wpb 3836.8 | bsz 289.6 | num_updates 317 | lr 6.34e-07 | gnorm 25.011 | loss_scale 2 | train_wall 64 | wall 98
2021-01-19 05:31:20 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-19 05:31:36 | INFO | train_inner | epoch 002:     83 / 324 loss=3.695, nll_loss=1.981, ppl=3.95, wps=8962, ups=2.34, wpb=3827.6, bsz=286.3, num_updates=400, lr=8e-07, gnorm=8.831, loss_scale=1, train_wall=19, wall=114
2021-01-19 05:31:55 | INFO | train_inner | epoch 002:    183 / 324 loss=3.281, nll_loss=1.498, ppl=2.83, wps=20001.3, ups=5.16, wpb=3874.2, bsz=296.3, num_updates=500, lr=1e-06, gnorm=6.895, loss_scale=1, train_wall=19, wall=133
2021-01-19 05:32:15 | INFO | train_inner | epoch 002:    283 / 324 loss=3.129, nll_loss=1.332, ppl=2.52, wps=19644.5, ups=5.16, wpb=3806.4, bsz=285, num_updates=600, lr=1.2e-06, gnorm=5.419, loss_scale=1, train_wall=19, wall=153
2021-01-19 05:32:23 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:32:23 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:32:23 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:32:24 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:32:24 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:32:25 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:32:25 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:32:27 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). In the studies, actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well blood sugar is regulated. What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:32:27 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:32:27 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 3.995 | nll_loss 2.245 | ppl 4.74 | bleu 33.81 | wps 888.5 | wpb 1083 | bsz 37.8 | num_updates 641 | best_loss 3.971
2021-01-19 05:32:27 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:32:34 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 2 @ 641 updates, score 3.995) (writing took 6.123062568251044 seconds)
2021-01-19 05:32:34 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-01-19 05:32:34 | INFO | train | epoch 002 | loss 3.286 | nll_loss 1.511 | ppl 2.85 | wps 16909.1 | ups 4.41 | wpb 3838.4 | bsz 290.1 | num_updates 641 | lr 1.282e-06 | gnorm 6.623 | loss_scale 1 | train_wall 62 | wall 171
2021-01-19 05:32:34 | INFO | fairseq_cli.train | begin training epoch 2
2021-01-19 05:32:45 | INFO | train_inner | epoch 003:     59 / 324 loss=2.92, nll_loss=1.104, ppl=2.15, wps=12753.2, ups=3.31, wpb=3854.1, bsz=299.6, num_updates=700, lr=1.4e-06, gnorm=4.749, loss_scale=1, train_wall=19, wall=183
2021-01-19 05:33:04 | INFO | train_inner | epoch 003:    159 / 324 loss=3.02, nll_loss=1.227, ppl=2.34, wps=19510.9, ups=5.2, wpb=3749.8, bsz=275.5, num_updates=800, lr=1.6e-06, gnorm=4.701, loss_scale=1, train_wall=19, wall=202
2021-01-19 05:33:24 | INFO | train_inner | epoch 003:    259 / 324 loss=2.807, nll_loss=0.99, ppl=1.99, wps=20049, ups=5.13, wpb=3906.6, bsz=296.4, num_updates=900, lr=1.8e-06, gnorm=3.814, loss_scale=1, train_wall=19, wall=221
2021-01-19 05:33:36 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:33:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:33:37 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:33:38 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:33:38 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:33:39 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:33:39 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:33:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). In the studies, actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration of a substance in the blood called glycosylated haemoglobin (HbA1c), which indicates how well blood sugar is regulated. What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:33:41 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:33:41 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 3.99 | nll_loss 2.2 | ppl 4.6 | bleu 33.08 | wps 903.7 | wpb 1083 | bsz 37.8 | num_updates 965 | best_loss 3.971
2021-01-19 05:33:41 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:33:47 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 3 @ 965 updates, score 3.99) (writing took 5.641477111726999 seconds)
2021-01-19 05:33:47 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-01-19 05:33:47 | INFO | train | epoch 003 | loss 2.889 | nll_loss 1.08 | ppl 2.11 | wps 17026.1 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 965 | lr 1.93e-06 | gnorm 4.216 | loss_scale 1 | train_wall 62 | wall 244
2021-01-19 05:33:47 | INFO | fairseq_cli.train | begin training epoch 3
2021-01-19 05:33:53 | INFO | train_inner | epoch 004:     35 / 324 loss=2.809, nll_loss=0.996, ppl=1.99, wps=12916.9, ups=3.37, wpb=3836.2, bsz=291.6, num_updates=1000, lr=2e-06, gnorm=3.819, loss_scale=1, train_wall=19, wall=251
2021-01-19 05:34:13 | INFO | train_inner | epoch 004:    135 / 324 loss=2.726, nll_loss=0.906, ppl=1.87, wps=19899.5, ups=5.17, wpb=3851.4, bsz=290.9, num_updates=1100, lr=2.2e-06, gnorm=3.979, loss_scale=1, train_wall=19, wall=271
2021-01-19 05:34:32 | INFO | train_inner | epoch 004:    235 / 324 loss=2.687, nll_loss=0.863, ppl=1.82, wps=19882.3, ups=5.16, wpb=3854.3, bsz=290.8, num_updates=1200, lr=2.4e-06, gnorm=3.025, loss_scale=1, train_wall=19, wall=290
2021-01-19 05:34:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:34:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:34:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:34:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:34:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:34:52 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:34:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:34:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, actrapid was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well blood sugar is regulated. What benefit has actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:34:54 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:34:54 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 3.954 | nll_loss 2.138 | ppl 4.4 | bleu 33.89 | wps 909.7 | wpb 1083 | bsz 37.8 | num_updates 1289 | best_loss 3.954
2021-01-19 05:34:54 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:35:13 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_best.pt (epoch 4 @ 1289 updates, score 3.954) (writing took 18.785468441899866 seconds)
2021-01-19 05:35:13 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-01-19 05:35:13 | INFO | train | epoch 004 | loss 2.712 | nll_loss 0.891 | ppl 1.85 | wps 14433.9 | ups 3.76 | wpb 3838.4 | bsz 290.1 | num_updates 1289 | lr 2.578e-06 | gnorm 3.469 | loss_scale 1 | train_wall 62 | wall 330
2021-01-19 05:35:13 | INFO | fairseq_cli.train | begin training epoch 4
2021-01-19 05:35:15 | INFO | train_inner | epoch 005:     11 / 324 loss=2.683, nll_loss=0.86, ppl=1.82, wps=8921.3, ups=2.33, wpb=3823.1, bsz=286, num_updates=1300, lr=2.6e-06, gnorm=3.11, loss_scale=1, train_wall=19, wall=333
2021-01-19 05:35:34 | INFO | train_inner | epoch 005:    111 / 324 loss=2.633, nll_loss=0.805, ppl=1.75, wps=19868.1, ups=5.19, wpb=3827.1, bsz=287.1, num_updates=1400, lr=2.8e-06, gnorm=2.744, loss_scale=1, train_wall=19, wall=352
2021-01-19 05:35:54 | INFO | train_inner | epoch 005:    211 / 324 loss=2.587, nll_loss=0.755, ppl=1.69, wps=19875, ups=5.18, wpb=3839.7, bsz=292, num_updates=1500, lr=3e-06, gnorm=2.86, loss_scale=1, train_wall=19, wall=371
2021-01-19 05:36:13 | INFO | train_inner | epoch 005:    311 / 324 loss=2.579, nll_loss=0.751, ppl=1.68, wps=19888.6, ups=5.16, wpb=3854.6, bsz=293.6, num_updates=1600, lr=3.2e-06, gnorm=2.654, loss_scale=1, train_wall=19, wall=391
2021-01-19 05:36:15 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:36:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:36:16 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:36:17 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:36:17 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:36:18 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:36:18 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:36:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) in the blood that indicates how well blood sugar is regulated. What benefit has actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with actrapid.
2021-01-19 05:36:20 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:36:20 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 3.908 | nll_loss 2.079 | ppl 4.22 | bleu 34.29 | wps 924.6 | wpb 1083 | bsz 37.8 | num_updates 1613 | best_loss 3.908
2021-01-19 05:36:20 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:36:38 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_best.pt (epoch 5 @ 1613 updates, score 3.908) (writing took 18.420001538004726 seconds)
2021-01-19 05:36:38 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-01-19 05:36:38 | INFO | train | epoch 005 | loss 2.606 | nll_loss 0.778 | ppl 1.71 | wps 14515.3 | ups 3.78 | wpb 3838.4 | bsz 290.1 | num_updates 1613 | lr 3.226e-06 | gnorm 2.762 | loss_scale 1 | train_wall 62 | wall 416
2021-01-19 05:36:38 | INFO | fairseq_cli.train | begin training epoch 5
2021-01-19 05:36:55 | INFO | train_inner | epoch 006:     87 / 324 loss=2.585, nll_loss=0.756, ppl=1.69, wps=9009.6, ups=2.36, wpb=3812.1, bsz=286.2, num_updates=1700, lr=3.4e-06, gnorm=2.635, loss_scale=1, train_wall=19, wall=433
2021-01-19 05:37:15 | INFO | train_inner | epoch 006:    187 / 324 loss=2.511, nll_loss=0.676, ppl=1.6, wps=20013.3, ups=5.15, wpb=3884.5, bsz=295.1, num_updates=1800, lr=3.6e-06, gnorm=2.51, loss_scale=1, train_wall=19, wall=452
2021-01-19 05:37:34 | INFO | train_inner | epoch 006:    287 / 324 loss=2.596, nll_loss=0.773, ppl=1.71, wps=19587.7, ups=5.22, wpb=3751.4, bsz=282.2, num_updates=1900, lr=3.8e-06, gnorm=2.613, loss_scale=1, train_wall=19, wall=472
2021-01-19 05:37:41 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:37:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:37:42 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:37:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin products.
2021-01-19 05:37:42 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:37:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Occasional peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:37:43 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:37:46 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP Actrapid has been compared to a human insulin analogue (insulin Aspart) by measuring the concentration of a substance in the blood known as glycosylated haemoglobin (HbA1c), indicating how well blood sugar is regulated. UNKNOWNTOKENINHYP What benefit has actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with actrapid.
2021-01-19 05:37:46 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:37:46 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 3.886 | nll_loss 2.046 | ppl 4.13 | bleu 37.1 | wps 909.8 | wpb 1083 | bsz 37.8 | num_updates 1937 | best_loss 3.886
2021-01-19 05:37:46 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:38:05 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_best.pt (epoch 6 @ 1937 updates, score 3.886) (writing took 18.95373294595629 seconds)
2021-01-19 05:38:05 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-01-19 05:38:05 | INFO | train | epoch 006 | loss 2.534 | nll_loss 0.703 | ppl 1.63 | wps 14426.3 | ups 3.76 | wpb 3838.4 | bsz 290.1 | num_updates 1937 | lr 3.874e-06 | gnorm 2.519 | loss_scale 1 | train_wall 62 | wall 502
2021-01-19 05:38:05 | INFO | fairseq_cli.train | begin training epoch 6
2021-01-19 05:38:17 | INFO | train_inner | epoch 007:     63 / 324 loss=2.473, nll_loss=0.635, ppl=1.55, wps=9075.6, ups=2.33, wpb=3903, bsz=293.4, num_updates=2000, lr=4e-06, gnorm=2.42, loss_scale=1, train_wall=19, wall=515
2021-01-19 05:38:36 | INFO | train_inner | epoch 007:    163 / 324 loss=2.465, nll_loss=0.626, ppl=1.54, wps=19853.9, ups=5.17, wpb=3840.9, bsz=291.3, num_updates=2100, lr=4.2e-06, gnorm=2.128, loss_scale=1, train_wall=19, wall=534
2021-01-19 05:38:55 | INFO | train_inner | epoch 007:    263 / 324 loss=2.542, nll_loss=0.715, ppl=1.64, wps=19747, ups=5.21, wpb=3790.6, bsz=279.4, num_updates=2200, lr=4.4e-06, gnorm=2.39, loss_scale=1, train_wall=19, wall=553
2021-01-19 05:39:07 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:39:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:39:08 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:39:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast acting insulin and can be used together with long acting insulin products.
2021-01-19 05:39:09 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:39:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Occasional peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:39:10 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:39:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) indicating how well glucose is regulated. UNKNOWNTOKENINHYP What benefit has actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with actrapid.
2021-01-19 05:39:12 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:39:12 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 3.871 | nll_loss 2.036 | ppl 4.1 | bleu 36.75 | wps 870.7 | wpb 1083 | bsz 37.8 | num_updates 2261 | best_loss 3.871
2021-01-19 05:39:12 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:39:31 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_best.pt (epoch 7 @ 2261 updates, score 3.871) (writing took 18.844057546928525 seconds)
2021-01-19 05:39:31 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-01-19 05:39:31 | INFO | train | epoch 007 | loss 2.486 | nll_loss 0.651 | ppl 1.57 | wps 14419.1 | ups 3.76 | wpb 3838.4 | bsz 290.1 | num_updates 2261 | lr 4.522e-06 | gnorm 2.218 | loss_scale 1 | train_wall 62 | wall 589
2021-01-19 05:39:31 | INFO | fairseq_cli.train | begin training epoch 7
2021-01-19 05:39:38 | INFO | train_inner | epoch 008:     39 / 324 loss=2.41, nll_loss=0.57, ppl=1.48, wps=9002.3, ups=2.32, wpb=3877.8, bsz=302.6, num_updates=2300, lr=4.6e-06, gnorm=1.787, loss_scale=1, train_wall=19, wall=596
2021-01-19 05:39:58 | INFO | train_inner | epoch 008:    139 / 324 loss=2.442, nll_loss=0.609, ppl=1.52, wps=20054.8, ups=5.19, wpb=3865.5, bsz=298.1, num_updates=2400, lr=4.8e-06, gnorm=2.074, loss_scale=1, train_wall=19, wall=616
2021-01-19 05:40:17 | INFO | train_inner | epoch 008:    239 / 324 loss=2.448, nll_loss=0.61, ppl=1.53, wps=19694.8, ups=5.18, wpb=3804.4, bsz=282.4, num_updates=2500, lr=5e-06, gnorm=2.092, loss_scale=1, train_wall=19, wall=635
2021-01-19 05:40:34 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:40:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:40:34 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:40:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast acting insulin and can be used together with long acting insulin products.
2021-01-19 05:40:35 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:40:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and usually reversible.
2021-01-19 05:40:36 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:40:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) indicating how well glucose is regulated. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:40:38 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:40:38 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 3.876 | nll_loss 2.038 | ppl 4.11 | bleu 36.58 | wps 894.5 | wpb 1083 | bsz 37.8 | num_updates 2585 | best_loss 3.871
2021-01-19 05:40:38 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:40:46 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 8 @ 2585 updates, score 3.876) (writing took 7.382351289037615 seconds)
2021-01-19 05:40:46 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-01-19 05:40:46 | INFO | train | epoch 008 | loss 2.449 | nll_loss 0.613 | ppl 1.53 | wps 16649.3 | ups 4.34 | wpb 3838.4 | bsz 290.1 | num_updates 2585 | lr 5.17e-06 | gnorm 2.05 | loss_scale 1 | train_wall 62 | wall 663
2021-01-19 05:40:46 | INFO | fairseq_cli.train | begin training epoch 8
2021-01-19 05:40:49 | INFO | train_inner | epoch 009:     15 / 324 loss=2.437, nll_loss=0.6, ppl=1.52, wps=12240.2, ups=3.17, wpb=3855.7, bsz=289.8, num_updates=2600, lr=5.2e-06, gnorm=1.991, loss_scale=1, train_wall=19, wall=666
2021-01-19 05:41:08 | INFO | train_inner | epoch 009:    115 / 324 loss=2.447, nll_loss=0.614, ppl=1.53, wps=19891.5, ups=5.17, wpb=3843.8, bsz=290.9, num_updates=2700, lr=5.4e-06, gnorm=2.03, loss_scale=1, train_wall=19, wall=686
2021-01-19 05:41:27 | INFO | train_inner | epoch 009:    215 / 324 loss=2.405, nll_loss=0.563, ppl=1.48, wps=19773.5, ups=5.17, wpb=3826.2, bsz=282.9, num_updates=2800, lr=5.6e-06, gnorm=1.868, loss_scale=1, train_wall=19, wall=705
2021-01-19 05:41:47 | INFO | train_inner | epoch 009:    315 / 324 loss=2.41, nll_loss=0.573, ppl=1.49, wps=19937.3, ups=5.19, wpb=3840.8, bsz=295.4, num_updates=2900, lr=5.8e-06, gnorm=1.691, loss_scale=1, train_wall=19, wall=724
2021-01-19 05:41:48 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:41:49 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:41:49 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:41:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin products.
2021-01-19 05:41:50 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:41:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:41:50 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:41:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid has been investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c) indicating how well glucose is regulated. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:41:53 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:41:53 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 3.877 | nll_loss 2.036 | ppl 4.1 | bleu 37.23 | wps 910 | wpb 1083 | bsz 37.8 | num_updates 2909 | best_loss 3.871
2021-01-19 05:41:53 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:42:01 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 9 @ 2909 updates, score 3.877) (writing took 7.966780414804816 seconds)
2021-01-19 05:42:01 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-01-19 05:42:01 | INFO | train | epoch 009 | loss 2.417 | nll_loss 0.58 | ppl 1.49 | wps 16522 | ups 4.3 | wpb 3838.4 | bsz 290.1 | num_updates 2909 | lr 5.818e-06 | gnorm 1.887 | loss_scale 1 | train_wall 62 | wall 739
2021-01-19 05:42:01 | INFO | fairseq_cli.train | begin training epoch 9
2021-01-19 05:42:19 | INFO | train_inner | epoch 010:     91 / 324 loss=2.382, nll_loss=0.541, ppl=1.45, wps=12011.5, ups=3.12, wpb=3846.6, bsz=290, num_updates=3000, lr=6e-06, gnorm=1.887, loss_scale=1, train_wall=19, wall=756
2021-01-19 05:42:38 | INFO | train_inner | epoch 010:    191 / 324 loss=2.379, nll_loss=0.539, ppl=1.45, wps=19831.1, ups=5.17, wpb=3839, bsz=293.9, num_updates=3100, lr=6.2e-06, gnorm=1.777, loss_scale=1, train_wall=19, wall=776
2021-01-19 05:42:57 | INFO | train_inner | epoch 010:    291 / 324 loss=2.404, nll_loss=0.566, ppl=1.48, wps=19862.7, ups=5.18, wpb=3835.7, bsz=287.2, num_updates=3200, lr=6.4e-06, gnorm=1.647, loss_scale=1, train_wall=19, wall=795
2021-01-19 05:43:04 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:43:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:43:04 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:43:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long acting insulin products.
2021-01-19 05:43:05 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:43:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:43:06 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:43:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid has been investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance known as glycosylated haemoglobin (HbA1c) indicating how well glucose is regulated. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:43:08 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:43:08 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 3.899 | nll_loss 2.063 | ppl 4.18 | bleu 37.25 | wps 946.2 | wpb 1083 | bsz 37.8 | num_updates 3233 | best_loss 3.871
2021-01-19 05:43:08 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:43:13 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 10 @ 3233 updates, score 3.899) (writing took 5.297753346152604 seconds)
2021-01-19 05:43:13 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-01-19 05:43:13 | INFO | train | epoch 010 | loss 2.39 | nll_loss 0.551 | ppl 1.46 | wps 17156.3 | ups 4.47 | wpb 3838.4 | bsz 290.1 | num_updates 3233 | lr 6.466e-06 | gnorm 1.74 | loss_scale 1 | train_wall 62 | wall 811
2021-01-19 05:43:13 | INFO | fairseq_cli.train | begin training epoch 10
2021-01-19 05:43:26 | INFO | train_inner | epoch 011:     67 / 324 loss=2.385, nll_loss=0.546, ppl=1.46, wps=13110.7, ups=3.44, wpb=3815.7, bsz=288.5, num_updates=3300, lr=6.6e-06, gnorm=1.713, loss_scale=1, train_wall=19, wall=824
2021-01-19 05:43:46 | INFO | train_inner | epoch 011:    167 / 324 loss=2.362, nll_loss=0.52, ppl=1.43, wps=19704.4, ups=5.15, wpb=3827, bsz=288.4, num_updates=3400, lr=6.8e-06, gnorm=1.543, loss_scale=1, train_wall=19, wall=843
2021-01-19 05:44:05 | INFO | train_inner | epoch 011:    267 / 324 loss=2.356, nll_loss=0.515, ppl=1.43, wps=19899.1, ups=5.17, wpb=3851.2, bsz=291.9, num_updates=3500, lr=7e-06, gnorm=1.602, loss_scale=1, train_wall=19, wall=863
2021-01-19 05:44:16 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:44:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:44:17 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:44:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is fast-acting insulin and can be used in conjunction with long acting insulin products.
2021-01-19 05:44:17 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:44:18 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:44:18 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:44:21 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid has been investigated in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (a trial involving 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance known as glycosylated haemoglobin (HbA1c) indicating how well glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:44:21 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:44:21 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 3.903 | nll_loss 2.07 | ppl 4.2 | bleu 37.99 | wps 903.9 | wpb 1083 | bsz 37.8 | num_updates 3557 | best_loss 3.871
2021-01-19 05:44:21 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:44:27 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 11 @ 3557 updates, score 3.903) (writing took 6.0660531600005925 seconds)
2021-01-19 05:44:27 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-01-19 05:44:27 | INFO | train | epoch 011 | loss 2.367 | nll_loss 0.526 | ppl 1.44 | wps 16928.3 | ups 4.41 | wpb 3838.4 | bsz 290.1 | num_updates 3557 | lr 7.114e-06 | gnorm 1.616 | loss_scale 1 | train_wall 62 | wall 885
2021-01-19 05:44:27 | INFO | fairseq_cli.train | begin training epoch 11
2021-01-19 05:44:35 | INFO | train_inner | epoch 012:     43 / 324 loss=2.37, nll_loss=0.531, ppl=1.45, wps=12794.8, ups=3.32, wpb=3850.6, bsz=293.4, num_updates=3600, lr=7.2e-06, gnorm=1.653, loss_scale=1, train_wall=19, wall=893
2021-01-19 05:44:55 | INFO | train_inner | epoch 012:    143 / 324 loss=2.333, nll_loss=0.489, ppl=1.4, wps=19935.8, ups=5.16, wpb=3866.9, bsz=294.1, num_updates=3700, lr=7.4e-06, gnorm=1.52, loss_scale=1, train_wall=19, wall=912
2021-01-19 05:45:14 | INFO | train_inner | epoch 012:    243 / 324 loss=2.319, nll_loss=0.474, ppl=1.39, wps=19894.9, ups=5.16, wpb=3852.4, bsz=296.1, num_updates=3800, lr=7.6e-06, gnorm=1.64, loss_scale=1, train_wall=19, wall=932
2021-01-19 05:45:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:45:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:45:30 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:45:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used in conjunction with long-acting insulin products.
2021-01-19 05:45:31 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:45:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:45:32 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:45:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid has been investigated in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (a trial involving 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid has been compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance known as glycosylated haemoglobin (HbA1c) indicating how well glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:45:34 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:45:34 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 3.927 | nll_loss 2.092 | ppl 4.26 | bleu 37.63 | wps 917.1 | wpb 1083 | bsz 37.8 | num_updates 3881 | best_loss 3.871
2021-01-19 05:45:34 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:45:40 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 12 @ 3881 updates, score 3.927) (writing took 6.155359884724021 seconds)
2021-01-19 05:45:40 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-01-19 05:45:40 | INFO | train | epoch 012 | loss 2.346 | nll_loss 0.503 | ppl 1.42 | wps 16923.8 | ups 4.41 | wpb 3838.4 | bsz 290.1 | num_updates 3881 | lr 7.762e-06 | gnorm 1.598 | loss_scale 1 | train_wall 62 | wall 958
2021-01-19 05:45:40 | INFO | fairseq_cli.train | begin training epoch 12
2021-01-19 05:45:44 | INFO | train_inner | epoch 013:     19 / 324 loss=2.386, nll_loss=0.547, ppl=1.46, wps=12649.6, ups=3.32, wpb=3807.3, bsz=280.5, num_updates=3900, lr=7.8e-06, gnorm=1.601, loss_scale=1, train_wall=19, wall=962
2021-01-19 05:46:03 | INFO | train_inner | epoch 013:    119 / 324 loss=2.303, nll_loss=0.456, ppl=1.37, wps=19909, ups=5.15, wpb=3862.6, bsz=291.7, num_updates=4000, lr=8e-06, gnorm=1.337, loss_scale=1, train_wall=19, wall=981
2021-01-19 05:46:23 | INFO | train_inner | epoch 013:    219 / 324 loss=2.361, nll_loss=0.521, ppl=1.44, wps=19876.8, ups=5.17, wpb=3842.5, bsz=288.3, num_updates=4100, lr=7.90184e-06, gnorm=1.507, loss_scale=1, train_wall=19, wall=1001
2021-01-19 05:46:42 | INFO | train_inner | epoch 013:    319 / 324 loss=2.317, nll_loss=0.472, ppl=1.39, wps=19583.4, ups=5.17, wpb=3789.4, bsz=287.6, num_updates=4200, lr=7.8072e-06, gnorm=1.47, loss_scale=1, train_wall=19, wall=1020
2021-01-19 05:46:43 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:46:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:46:44 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:46:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:46:44 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:46:45 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:46:45 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:46:47 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide has been compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) indicating how well glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:46:47 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:46:47 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 3.971 | nll_loss 2.141 | ppl 4.41 | bleu 37.19 | wps 962.2 | wpb 1083 | bsz 37.8 | num_updates 4205 | best_loss 3.871
2021-01-19 05:46:47 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:46:54 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 13 @ 4205 updates, score 3.971) (writing took 6.8924712161533535 seconds)
2021-01-19 05:46:54 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-01-19 05:46:54 | INFO | train | epoch 013 | loss 2.326 | nll_loss 0.483 | ppl 1.4 | wps 16779.6 | ups 4.37 | wpb 3838.4 | bsz 290.1 | num_updates 4205 | lr 7.80256e-06 | gnorm 1.434 | loss_scale 1 | train_wall 62 | wall 1032
2021-01-19 05:46:54 | INFO | fairseq_cli.train | begin training epoch 13
2021-01-19 05:47:13 | INFO | train_inner | epoch 014:     95 / 324 loss=2.32, nll_loss=0.475, ppl=1.39, wps=12516, ups=3.26, wpb=3841.7, bsz=284, num_updates=4300, lr=7.71589e-06, gnorm=1.489, loss_scale=1, train_wall=19, wall=1051
2021-01-19 05:47:32 | INFO | train_inner | epoch 014:    195 / 324 loss=2.323, nll_loss=0.479, ppl=1.39, wps=19560.7, ups=5.16, wpb=3792.8, bsz=284.4, num_updates=4400, lr=7.6277e-06, gnorm=1.405, loss_scale=1, train_wall=19, wall=1070
2021-01-19 05:47:52 | INFO | train_inner | epoch 014:    295 / 324 loss=2.287, nll_loss=0.441, ppl=1.36, wps=20101.2, ups=5.17, wpb=3889.5, bsz=300, num_updates=4500, lr=7.54247e-06, gnorm=1.239, loss_scale=1, train_wall=19, wall=1089
2021-01-19 05:47:57 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:47:58 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:47:58 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:47:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:47:59 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:47:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:47:59 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:48:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) indicating how well glucose is controlled. What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:48:02 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:48:02 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 3.992 | nll_loss 2.169 | ppl 4.5 | bleu 36.91 | wps 900.4 | wpb 1083 | bsz 37.8 | num_updates 4529 | best_loss 3.871
2021-01-19 05:48:02 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:48:08 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 14 @ 4529 updates, score 3.992) (writing took 5.859070403967053 seconds)
2021-01-19 05:48:08 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-01-19 05:48:08 | INFO | train | epoch 014 | loss 2.309 | nll_loss 0.464 | ppl 1.38 | wps 16972.2 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 4529 | lr 7.51829e-06 | gnorm 1.376 | loss_scale 1 | train_wall 62 | wall 1105
2021-01-19 05:48:08 | INFO | fairseq_cli.train | begin training epoch 14
2021-01-19 05:48:22 | INFO | train_inner | epoch 015:     71 / 324 loss=2.294, nll_loss=0.448, ppl=1.36, wps=12782.3, ups=3.34, wpb=3830.6, bsz=295.1, num_updates=4600, lr=7.46004e-06, gnorm=1.27, loss_scale=1, train_wall=19, wall=1119
2021-01-19 05:48:41 | INFO | train_inner | epoch 015:    171 / 324 loss=2.279, nll_loss=0.432, ppl=1.35, wps=19947.2, ups=5.19, wpb=3845.2, bsz=292.3, num_updates=4700, lr=7.38025e-06, gnorm=1.341, loss_scale=1, train_wall=19, wall=1139
2021-01-19 05:49:00 | INFO | train_inner | epoch 015:    271 / 324 loss=2.298, nll_loss=0.452, ppl=1.37, wps=19826, ups=5.15, wpb=3851.7, bsz=289.9, num_updates=4800, lr=7.30297e-06, gnorm=1.314, loss_scale=1, train_wall=19, wall=1158
2021-01-19 05:49:10 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:49:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:49:11 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:49:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:49:12 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:49:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:49:13 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:49:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body cannot process insulin effectively (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance known as glycosylated haemoglobin (HbA1c) that indicates how well glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:49:15 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:49:15 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 3.977 | nll_loss 2.152 | ppl 4.44 | bleu 37.49 | wps 934.3 | wpb 1083 | bsz 37.8 | num_updates 4853 | best_loss 3.871
2021-01-19 05:49:15 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:49:21 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 15 @ 4853 updates, score 3.977) (writing took 5.668329660315067 seconds)
2021-01-19 05:49:21 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-01-19 05:49:21 | INFO | train | epoch 015 | loss 2.295 | nll_loss 0.45 | ppl 1.37 | wps 17043.4 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 4853 | lr 7.26298e-06 | gnorm 1.327 | loss_scale 1 | train_wall 62 | wall 1178
2021-01-19 05:49:21 | INFO | fairseq_cli.train | begin training epoch 15
2021-01-19 05:49:30 | INFO | train_inner | epoch 016:     47 / 324 loss=2.328, nll_loss=0.483, ppl=1.4, wps=12735.2, ups=3.4, wpb=3747.4, bsz=272.6, num_updates=4900, lr=7.22806e-06, gnorm=1.513, loss_scale=1, train_wall=19, wall=1187
2021-01-19 05:49:49 | INFO | train_inner | epoch 016:    147 / 324 loss=2.265, nll_loss=0.417, ppl=1.33, wps=20071.6, ups=5.16, wpb=3886.7, bsz=296.1, num_updates=5000, lr=7.15542e-06, gnorm=1.153, loss_scale=1, train_wall=19, wall=1207
2021-01-19 05:50:08 | INFO | train_inner | epoch 016:    247 / 324 loss=2.315, nll_loss=0.473, ppl=1.39, wps=19995.6, ups=5.16, wpb=3875.7, bsz=291.1, num_updates=5100, lr=7.08492e-06, gnorm=1.306, loss_scale=1, train_wall=19, wall=1226
2021-01-19 05:50:23 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:50:24 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:50:24 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:50:25 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:50:25 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:50:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:50:26 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:50:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in which the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:50:28 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:50:28 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 4.026 | nll_loss 2.209 | ppl 4.62 | bleu 37.22 | wps 965.5 | wpb 1083 | bsz 37.8 | num_updates 5177 | best_loss 3.871
2021-01-19 05:50:28 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:50:34 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 16 @ 5177 updates, score 4.026) (writing took 6.22604461107403 seconds)
2021-01-19 05:50:34 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-01-19 05:50:34 | INFO | train | epoch 016 | loss 2.283 | nll_loss 0.436 | ppl 1.35 | wps 16956.4 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 5177 | lr 7.03203e-06 | gnorm 1.248 | loss_scale 1 | train_wall 62 | wall 1252
2021-01-19 05:50:34 | INFO | fairseq_cli.train | begin training epoch 16
2021-01-19 05:50:39 | INFO | train_inner | epoch 017:     23 / 324 loss=2.228, nll_loss=0.377, ppl=1.3, wps=12759, ups=3.32, wpb=3839.4, bsz=297.8, num_updates=5200, lr=7.01646e-06, gnorm=1.091, loss_scale=1, train_wall=19, wall=1256
2021-01-19 05:50:58 | INFO | train_inner | epoch 017:    123 / 324 loss=2.265, nll_loss=0.417, ppl=1.34, wps=19954.3, ups=5.14, wpb=3879.3, bsz=294.6, num_updates=5300, lr=6.94996e-06, gnorm=1.111, loss_scale=1, train_wall=19, wall=1276
2021-01-19 05:51:17 | INFO | train_inner | epoch 017:    223 / 324 loss=2.292, nll_loss=0.446, ppl=1.36, wps=19830.4, ups=5.18, wpb=3829.4, bsz=284.9, num_updates=5400, lr=6.8853e-06, gnorm=1.336, loss_scale=1, train_wall=19, wall=1295
2021-01-19 05:51:37 | INFO | train_inner | epoch 017:    323 / 324 loss=2.278, nll_loss=0.431, ppl=1.35, wps=19691.5, ups=5.19, wpb=3797, bsz=288, num_updates=5500, lr=6.82242e-06, gnorm=1.256, loss_scale=1, train_wall=19, wall=1314
2021-01-19 05:51:37 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:51:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:51:37 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:51:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:51:38 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:51:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:51:39 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:51:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:51:41 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:51:41 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 4.008 | nll_loss 2.184 | ppl 4.54 | bleu 37.75 | wps 917.3 | wpb 1083 | bsz 37.8 | num_updates 5501 | best_loss 3.871
2021-01-19 05:51:41 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:51:47 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 17 @ 5501 updates, score 4.008) (writing took 5.7131038447842 seconds)
2021-01-19 05:51:47 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-01-19 05:51:47 | INFO | train | epoch 017 | loss 2.272 | nll_loss 0.424 | ppl 1.34 | wps 17025.2 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 5501 | lr 6.8218e-06 | gnorm 1.224 | loss_scale 1 | train_wall 62 | wall 1325
2021-01-19 05:51:47 | INFO | fairseq_cli.train | begin training epoch 17
2021-01-19 05:52:06 | INFO | train_inner | epoch 018:     99 / 324 loss=2.247, nll_loss=0.398, ppl=1.32, wps=13024.3, ups=3.36, wpb=3881.9, bsz=294.6, num_updates=5600, lr=6.76123e-06, gnorm=1.107, loss_scale=1, train_wall=19, wall=1344
2021-01-19 05:52:26 | INFO | train_inner | epoch 018:    199 / 324 loss=2.246, nll_loss=0.396, ppl=1.32, wps=19836.4, ups=5.17, wpb=3835.9, bsz=293.8, num_updates=5700, lr=6.70166e-06, gnorm=1.199, loss_scale=1, train_wall=19, wall=1363
2021-01-19 05:52:45 | INFO | train_inner | epoch 018:    299 / 324 loss=2.289, nll_loss=0.444, ppl=1.36, wps=19738.3, ups=5.18, wpb=3808.9, bsz=285.4, num_updates=5800, lr=6.64364e-06, gnorm=1.279, loss_scale=1, train_wall=19, wall=1383
2021-01-19 05:52:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:52:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:52:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:52:51 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:52:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:52:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:52:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:52:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:52:54 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:52:54 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 4.021 | nll_loss 2.202 | ppl 4.6 | bleu 37.38 | wps 911.6 | wpb 1083 | bsz 37.8 | num_updates 5825 | best_loss 3.871
2021-01-19 05:52:54 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:53:01 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 18 @ 5825 updates, score 4.021) (writing took 6.302965014707297 seconds)
2021-01-19 05:53:01 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-01-19 05:53:01 | INFO | train | epoch 018 | loss 2.263 | nll_loss 0.415 | ppl 1.33 | wps 16882 | ups 4.4 | wpb 3838.4 | bsz 290.1 | num_updates 5825 | lr 6.62937e-06 | gnorm 1.192 | loss_scale 1 | train_wall 62 | wall 1398
2021-01-19 05:53:01 | INFO | fairseq_cli.train | begin training epoch 18
2021-01-19 05:53:15 | INFO | train_inner | epoch 019:     75 / 324 loss=2.284, nll_loss=0.436, ppl=1.35, wps=12485.8, ups=3.3, wpb=3778.4, bsz=282.6, num_updates=5900, lr=6.5871e-06, gnorm=1.193, loss_scale=1, train_wall=19, wall=1413
2021-01-19 05:53:35 | INFO | train_inner | epoch 019:    175 / 324 loss=2.239, nll_loss=0.389, ppl=1.31, wps=20033.3, ups=5.16, wpb=3879.3, bsz=296.9, num_updates=6000, lr=6.53197e-06, gnorm=1.147, loss_scale=1, train_wall=19, wall=1432
2021-01-19 05:53:54 | INFO | train_inner | epoch 019:    275 / 324 loss=2.24, nll_loss=0.39, ppl=1.31, wps=19929.9, ups=5.18, wpb=3850.1, bsz=293.8, num_updates=6100, lr=6.47821e-06, gnorm=1.301, loss_scale=1, train_wall=19, wall=1452
2021-01-19 05:54:03 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:54:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:54:04 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:54:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 05:54:05 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:54:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:54:06 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:54:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:54:08 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:54:08 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 4.022 | nll_loss 2.207 | ppl 4.62 | bleu 38.21 | wps 908.5 | wpb 1083 | bsz 37.8 | num_updates 6149 | best_loss 3.871
2021-01-19 05:54:08 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:54:15 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 19 @ 6149 updates, score 4.022) (writing took 7.125024300068617 seconds)
2021-01-19 05:54:15 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-01-19 05:54:15 | INFO | train | epoch 019 | loss 2.255 | nll_loss 0.406 | ppl 1.32 | wps 16705.8 | ups 4.35 | wpb 3838.4 | bsz 290.1 | num_updates 6149 | lr 6.45235e-06 | gnorm 1.219 | loss_scale 1 | train_wall 62 | wall 1473
2021-01-19 05:54:15 | INFO | fairseq_cli.train | begin training epoch 19
2021-01-19 05:54:25 | INFO | train_inner | epoch 020:     51 / 324 loss=2.257, nll_loss=0.407, ppl=1.33, wps=12375.9, ups=3.2, wpb=3861.6, bsz=280.8, num_updates=6200, lr=6.42575e-06, gnorm=1.239, loss_scale=1, train_wall=19, wall=1483
2021-01-19 05:54:45 | INFO | train_inner | epoch 020:    151 / 324 loss=2.233, nll_loss=0.383, ppl=1.3, wps=19958.7, ups=5.16, wpb=3866.1, bsz=295.9, num_updates=6300, lr=6.37455e-06, gnorm=1.082, loss_scale=1, train_wall=19, wall=1502
2021-01-19 05:55:04 | INFO | train_inner | epoch 020:    251 / 324 loss=2.241, nll_loss=0.392, ppl=1.31, wps=19769.7, ups=5.17, wpb=3824.3, bsz=294.2, num_updates=6400, lr=6.32456e-06, gnorm=1.277, loss_scale=1, train_wall=19, wall=1522
2021-01-19 05:55:18 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:55:18 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:55:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:55:19 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 05:55:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:55:20 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:55:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:55:22 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial involving 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide has been compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:55:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:55:22 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 4.039 | nll_loss 2.227 | ppl 4.68 | bleu 37.97 | wps 956.3 | wpb 1083 | bsz 37.8 | num_updates 6473 | best_loss 3.871
2021-01-19 05:55:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:55:28 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 20 @ 6473 updates, score 4.039) (writing took 5.692692856770009 seconds)
2021-01-19 05:55:28 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-01-19 05:55:28 | INFO | train | epoch 020 | loss 2.247 | nll_loss 0.397 | ppl 1.32 | wps 17080.8 | ups 4.45 | wpb 3838.4 | bsz 290.1 | num_updates 6473 | lr 6.28879e-06 | gnorm 1.217 | loss_scale 1 | train_wall 62 | wall 1546
2021-01-19 05:55:28 | INFO | fairseq_cli.train | begin training epoch 20
2021-01-19 05:55:33 | INFO | train_inner | epoch 021:     27 / 324 loss=2.269, nll_loss=0.421, ppl=1.34, wps=12893.8, ups=3.4, wpb=3788.3, bsz=281.2, num_updates=6500, lr=6.27572e-06, gnorm=1.201, loss_scale=1, train_wall=19, wall=1551
2021-01-19 05:55:53 | INFO | train_inner | epoch 021:    127 / 324 loss=2.281, nll_loss=0.435, ppl=1.35, wps=19743.2, ups=5.19, wpb=3805.8, bsz=280.6, num_updates=6600, lr=6.22799e-06, gnorm=1.307, loss_scale=1, train_wall=19, wall=1570
2021-01-19 05:56:12 | INFO | train_inner | epoch 021:    227 / 324 loss=2.219, nll_loss=0.368, ppl=1.29, wps=19940.7, ups=5.16, wpb=3861.6, bsz=297.2, num_updates=6700, lr=6.18134e-06, gnorm=0.979, loss_scale=1, train_wall=19, wall=1590
2021-01-19 05:56:31 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:56:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:56:31 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:56:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 05:56:32 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:56:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:56:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:56:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:56:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:56:35 | INFO | valid | epoch 021 | valid on 'valid' subset | loss 4.091 | nll_loss 2.281 | ppl 4.86 | bleu 38.18 | wps 924.1 | wpb 1083 | bsz 37.8 | num_updates 6797 | best_loss 3.871
2021-01-19 05:56:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:56:44 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 21 @ 6797 updates, score 4.091) (writing took 8.33736626477912 seconds)
2021-01-19 05:56:44 | INFO | fairseq_cli.train | end of epoch 21 (average epoch stats below)
2021-01-19 05:56:44 | INFO | train | epoch 021 | loss 2.24 | nll_loss 0.39 | ppl 1.31 | wps 16442.8 | ups 4.28 | wpb 3838.4 | bsz 290.1 | num_updates 6797 | lr 6.13707e-06 | gnorm 1.212 | loss_scale 1 | train_wall 62 | wall 1621
2021-01-19 05:56:44 | INFO | fairseq_cli.train | begin training epoch 21
2021-01-19 05:56:44 | INFO | train_inner | epoch 022:      3 / 324 loss=2.218, nll_loss=0.366, ppl=1.29, wps=11917.9, ups=3.09, wpb=3857.3, bsz=293.9, num_updates=6800, lr=6.13572e-06, gnorm=1.401, loss_scale=1, train_wall=19, wall=1622
2021-01-19 05:57:03 | INFO | train_inner | epoch 022:    103 / 324 loss=2.261, nll_loss=0.413, ppl=1.33, wps=19731.7, ups=5.2, wpb=3794.2, bsz=283.6, num_updates=6900, lr=6.0911e-06, gnorm=1.402, loss_scale=1, train_wall=19, wall=1641
2021-01-19 05:57:23 | INFO | train_inner | epoch 022:    203 / 324 loss=2.239, nll_loss=0.388, ppl=1.31, wps=19829.1, ups=5.19, wpb=3823.4, bsz=288.2, num_updates=7000, lr=6.04743e-06, gnorm=1.103, loss_scale=1, train_wall=19, wall=1661
2021-01-19 05:57:42 | INFO | train_inner | epoch 022:    303 / 324 loss=2.214, nll_loss=0.361, ppl=1.28, wps=19928.1, ups=5.14, wpb=3873.9, bsz=291.6, num_updates=7100, lr=6.00469e-06, gnorm=1.143, loss_scale=1, train_wall=19, wall=1680
2021-01-19 05:57:46 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:57:47 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:57:47 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:57:48 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 05:57:48 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:57:49 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:57:49 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:57:51 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:57:51 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:57:51 | INFO | valid | epoch 022 | valid on 'valid' subset | loss 4.096 | nll_loss 2.287 | ppl 4.88 | bleu 37.98 | wps 916.8 | wpb 1083 | bsz 37.8 | num_updates 7121 | best_loss 3.871
2021-01-19 05:57:51 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:57:57 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 22 @ 7121 updates, score 4.096) (writing took 6.257742876186967 seconds)
2021-01-19 05:57:57 | INFO | fairseq_cli.train | end of epoch 22 (average epoch stats below)
2021-01-19 05:57:57 | INFO | train | epoch 022 | loss 2.234 | nll_loss 0.383 | ppl 1.3 | wps 16903.5 | ups 4.4 | wpb 3838.4 | bsz 290.1 | num_updates 7121 | lr 5.99583e-06 | gnorm 1.189 | loss_scale 1 | train_wall 62 | wall 1695
2021-01-19 05:57:57 | INFO | fairseq_cli.train | begin training epoch 22
2021-01-19 05:58:13 | INFO | train_inner | epoch 023:     79 / 324 loss=2.231, nll_loss=0.383, ppl=1.3, wps=12714.5, ups=3.3, wpb=3851.9, bsz=299.4, num_updates=7200, lr=5.96285e-06, gnorm=1.097, loss_scale=1, train_wall=19, wall=1710
2021-01-19 05:58:32 | INFO | train_inner | epoch 023:    179 / 324 loss=2.225, nll_loss=0.373, ppl=1.3, wps=19842.3, ups=5.17, wpb=3837.6, bsz=285, num_updates=7300, lr=5.92187e-06, gnorm=1.077, loss_scale=1, train_wall=19, wall=1730
2021-01-19 05:58:51 | INFO | train_inner | epoch 023:    279 / 324 loss=2.21, nll_loss=0.358, ppl=1.28, wps=19842.7, ups=5.16, wpb=3842.2, bsz=294.1, num_updates=7400, lr=5.88172e-06, gnorm=1.035, loss_scale=1, train_wall=19, wall=1749
2021-01-19 05:59:00 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:59:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:59:00 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:59:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 05:59:01 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:59:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 05:59:02 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:59:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 05:59:04 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:59:05 | INFO | valid | epoch 023 | valid on 'valid' subset | loss 4.072 | nll_loss 2.265 | ppl 4.81 | bleu 38.98 | wps 903.6 | wpb 1083 | bsz 37.8 | num_updates 7445 | best_loss 3.871
2021-01-19 05:59:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:59:12 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 23 @ 7445 updates, score 4.072) (writing took 7.134874333161861 seconds)
2021-01-19 05:59:12 | INFO | fairseq_cli.train | end of epoch 23 (average epoch stats below)
2021-01-19 05:59:12 | INFO | train | epoch 023 | loss 2.228 | nll_loss 0.377 | ppl 1.3 | wps 16696.3 | ups 4.35 | wpb 3838.4 | bsz 290.1 | num_updates 7445 | lr 5.86391e-06 | gnorm 1.1 | loss_scale 1 | train_wall 62 | wall 1769
2021-01-19 05:59:12 | INFO | fairseq_cli.train | begin training epoch 23
2021-01-19 05:59:22 | INFO | train_inner | epoch 024:     55 / 324 loss=2.239, nll_loss=0.389, ppl=1.31, wps=12353, ups=3.21, wpb=3848.8, bsz=288.6, num_updates=7500, lr=5.84237e-06, gnorm=1.061, loss_scale=1, train_wall=19, wall=1780
2021-01-19 05:59:42 | INFO | train_inner | epoch 024:    155 / 324 loss=2.23, nll_loss=0.38, ppl=1.3, wps=19907.3, ups=5.18, wpb=3846.2, bsz=289.8, num_updates=7600, lr=5.80381e-06, gnorm=1.12, loss_scale=1, train_wall=19, wall=1799
2021-01-19 06:00:01 | INFO | train_inner | epoch 024:    255 / 324 loss=2.213, nll_loss=0.361, ppl=1.28, wps=19781.5, ups=5.18, wpb=3815.6, bsz=291.6, num_updates=7700, lr=5.766e-06, gnorm=1.062, loss_scale=1, train_wall=19, wall=1819
2021-01-19 06:00:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:00:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:00:15 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:00:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:00:16 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:00:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:00:17 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:00:19 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide has been compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:00:19 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:00:19 | INFO | valid | epoch 024 | valid on 'valid' subset | loss 4.11 | nll_loss 2.306 | ppl 4.95 | bleu 38.03 | wps 905.9 | wpb 1083 | bsz 37.8 | num_updates 7769 | best_loss 3.871
2021-01-19 06:00:19 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:00:25 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 24 @ 7769 updates, score 4.11) (writing took 5.736235939897597 seconds)
2021-01-19 06:00:25 | INFO | fairseq_cli.train | end of epoch 24 (average epoch stats below)
2021-01-19 06:00:25 | INFO | train | epoch 024 | loss 2.222 | nll_loss 0.37 | ppl 1.29 | wps 17023.4 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 7769 | lr 5.74034e-06 | gnorm 1.055 | loss_scale 1 | train_wall 62 | wall 1842
2021-01-19 06:00:25 | INFO | fairseq_cli.train | begin training epoch 24
2021-01-19 06:00:31 | INFO | train_inner | epoch 025:     31 / 324 loss=2.21, nll_loss=0.356, ppl=1.28, wps=12974.3, ups=3.35, wpb=3873.3, bsz=285.4, num_updates=7800, lr=5.72892e-06, gnorm=1.068, loss_scale=1, train_wall=19, wall=1849
2021-01-19 06:00:50 | INFO | train_inner | epoch 025:    131 / 324 loss=2.233, nll_loss=0.384, ppl=1.3, wps=19951.6, ups=5.18, wpb=3849.3, bsz=292.1, num_updates=7900, lr=5.69254e-06, gnorm=1.123, loss_scale=1, train_wall=19, wall=1868
2021-01-19 06:01:10 | INFO | train_inner | epoch 025:    231 / 324 loss=2.196, nll_loss=0.343, ppl=1.27, wps=19793.5, ups=5.15, wpb=3841.4, bsz=293.2, num_updates=8000, lr=5.65685e-06, gnorm=1.214, loss_scale=1, train_wall=19, wall=1887
2021-01-19 06:01:27 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:01:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:01:28 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:01:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:01:29 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:01:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:01:30 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:01:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide has been investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). In the trials, Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled. What benefit has Actrapide shown in these trials? Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:01:32 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:01:32 | INFO | valid | epoch 025 | valid on 'valid' subset | loss 4.091 | nll_loss 2.286 | ppl 4.88 | bleu 38.12 | wps 889.9 | wpb 1083 | bsz 37.8 | num_updates 8093 | best_loss 3.871
2021-01-19 06:01:32 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:01:38 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 25 @ 8093 updates, score 4.091) (writing took 5.731191280763596 seconds)
2021-01-19 06:01:38 | INFO | fairseq_cli.train | end of epoch 25 (average epoch stats below)
2021-01-19 06:01:38 | INFO | train | epoch 025 | loss 2.216 | nll_loss 0.365 | ppl 1.29 | wps 16998.7 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 8093 | lr 5.62426e-06 | gnorm 1.16 | loss_scale 1 | train_wall 62 | wall 1916
2021-01-19 06:01:38 | INFO | fairseq_cli.train | begin training epoch 25
2021-01-19 06:01:39 | INFO | train_inner | epoch 026:      7 / 324 loss=2.224, nll_loss=0.375, ppl=1.3, wps=12772.1, ups=3.36, wpb=3801.5, bsz=290.1, num_updates=8100, lr=5.62183e-06, gnorm=1.132, loss_scale=1, train_wall=19, wall=1917
2021-01-19 06:01:59 | INFO | train_inner | epoch 026:    107 / 324 loss=2.209, nll_loss=0.355, ppl=1.28, wps=19776.4, ups=5.18, wpb=3816.4, bsz=284.6, num_updates=8200, lr=5.58744e-06, gnorm=1.018, loss_scale=1, train_wall=19, wall=1936
2021-01-19 06:02:18 | INFO | train_inner | epoch 026:    207 / 324 loss=2.219, nll_loss=0.368, ppl=1.29, wps=19944.1, ups=5.15, wpb=3873.6, bsz=293.9, num_updates=8300, lr=5.55368e-06, gnorm=1.037, loss_scale=1, train_wall=19, wall=1956
2021-01-19 06:02:37 | INFO | train_inner | epoch 026:    307 / 324 loss=2.22, nll_loss=0.369, ppl=1.29, wps=19743.6, ups=5.18, wpb=3808.1, bsz=286.4, num_updates=8400, lr=5.52052e-06, gnorm=1.179, loss_scale=1, train_wall=19, wall=1975
2021-01-19 06:02:41 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:02:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:02:41 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:02:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:02:42 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:02:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:02:43 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:02:45 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:02:45 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:02:45 | INFO | valid | epoch 026 | valid on 'valid' subset | loss 4.134 | nll_loss 2.334 | ppl 5.04 | bleu 38.23 | wps 901.7 | wpb 1083 | bsz 37.8 | num_updates 8417 | best_loss 3.871
2021-01-19 06:02:45 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:02:51 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 26 @ 8417 updates, score 4.134) (writing took 5.844989928882569 seconds)
2021-01-19 06:02:51 | INFO | fairseq_cli.train | end of epoch 26 (average epoch stats below)
2021-01-19 06:02:51 | INFO | train | epoch 026 | loss 2.212 | nll_loss 0.36 | ppl 1.28 | wps 16972.5 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 8417 | lr 5.51495e-06 | gnorm 1.064 | loss_scale 1 | train_wall 62 | wall 1989
2021-01-19 06:02:51 | INFO | fairseq_cli.train | begin training epoch 26
2021-01-19 06:03:07 | INFO | train_inner | epoch 027:     83 / 324 loss=2.203, nll_loss=0.351, ppl=1.28, wps=12875.5, ups=3.34, wpb=3858.2, bsz=293.2, num_updates=8500, lr=5.48795e-06, gnorm=1.027, loss_scale=1, train_wall=19, wall=2005
2021-01-19 06:03:27 | INFO | train_inner | epoch 027:    183 / 324 loss=2.207, nll_loss=0.355, ppl=1.28, wps=19983.8, ups=5.15, wpb=3876.8, bsz=293.3, num_updates=8600, lr=5.45595e-06, gnorm=1.03, loss_scale=1, train_wall=19, wall=2024
2021-01-19 06:03:46 | INFO | train_inner | epoch 027:    283 / 324 loss=2.191, nll_loss=0.338, ppl=1.26, wps=19832.8, ups=5.17, wpb=3835.1, bsz=294, num_updates=8700, lr=5.42451e-06, gnorm=0.966, loss_scale=1, train_wall=19, wall=2044
2021-01-19 06:03:54 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:03:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:03:54 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:03:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:03:55 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:03:56 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:03:56 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:03:58 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:03:58 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:03:58 | INFO | valid | epoch 027 | valid on 'valid' subset | loss 4.148 | nll_loss 2.35 | ppl 5.1 | bleu 38.39 | wps 935.8 | wpb 1083 | bsz 37.8 | num_updates 8741 | best_loss 3.871
2021-01-19 06:03:58 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:04:07 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 27 @ 8741 updates, score 4.148) (writing took 8.995801890734583 seconds)
2021-01-19 06:04:07 | INFO | fairseq_cli.train | end of epoch 27 (average epoch stats below)
2021-01-19 06:04:07 | INFO | train | epoch 027 | loss 2.207 | nll_loss 0.354 | ppl 1.28 | wps 16302.5 | ups 4.25 | wpb 3838.4 | bsz 290.1 | num_updates 8741 | lr 5.41177e-06 | gnorm 1.028 | loss_scale 1 | train_wall 62 | wall 2065
2021-01-19 06:04:07 | INFO | fairseq_cli.train | begin training epoch 27
2021-01-19 06:04:19 | INFO | train_inner | epoch 028:     59 / 324 loss=2.201, nll_loss=0.347, ppl=1.27, wps=11488.7, ups=3.04, wpb=3778.8, bsz=281, num_updates=8800, lr=5.3936e-06, gnorm=1.007, loss_scale=1, train_wall=19, wall=2077
2021-01-19 06:04:38 | INFO | train_inner | epoch 028:    159 / 324 loss=2.205, nll_loss=0.352, ppl=1.28, wps=19920.5, ups=5.17, wpb=3853.4, bsz=289.5, num_updates=8900, lr=5.36321e-06, gnorm=1.011, loss_scale=1, train_wall=19, wall=2096
2021-01-19 06:04:58 | INFO | train_inner | epoch 028:    259 / 324 loss=2.226, nll_loss=0.376, ppl=1.3, wps=19840, ups=5.17, wpb=3840.2, bsz=290.1, num_updates=9000, lr=5.33333e-06, gnorm=1.159, loss_scale=1, train_wall=19, wall=2115
2021-01-19 06:05:10 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:05:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:05:11 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:05:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:05:11 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:05:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:05:12 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:05:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:05:15 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:05:15 | INFO | valid | epoch 028 | valid on 'valid' subset | loss 4.176 | nll_loss 2.383 | ppl 5.22 | bleu 38.63 | wps 911.9 | wpb 1083 | bsz 37.8 | num_updates 9065 | best_loss 3.871
2021-01-19 06:05:15 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:05:22 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 28 @ 9065 updates, score 4.176) (writing took 7.723079354967922 seconds)
2021-01-19 06:05:22 | INFO | fairseq_cli.train | end of epoch 28 (average epoch stats below)
2021-01-19 06:05:22 | INFO | train | epoch 028 | loss 2.203 | nll_loss 0.35 | ppl 1.27 | wps 16577.2 | ups 4.32 | wpb 3838.4 | bsz 290.1 | num_updates 9065 | lr 5.31418e-06 | gnorm 1.019 | loss_scale 1 | train_wall 62 | wall 2140
2021-01-19 06:05:22 | INFO | fairseq_cli.train | begin training epoch 28
2021-01-19 06:05:29 | INFO | train_inner | epoch 029:     35 / 324 loss=2.195, nll_loss=0.344, ppl=1.27, wps=12221.1, ups=3.15, wpb=3874.9, bsz=297, num_updates=9100, lr=5.30395e-06, gnorm=0.922, loss_scale=1, train_wall=19, wall=2147
2021-01-19 06:05:49 | INFO | train_inner | epoch 029:    135 / 324 loss=2.189, nll_loss=0.335, ppl=1.26, wps=19975.7, ups=5.18, wpb=3854.6, bsz=292.9, num_updates=9200, lr=5.27504e-06, gnorm=0.951, loss_scale=1, train_wall=19, wall=2166
2021-01-19 06:06:08 | INFO | train_inner | epoch 029:    235 / 324 loss=2.192, nll_loss=0.338, ppl=1.26, wps=19792.8, ups=5.16, wpb=3833.1, bsz=287.4, num_updates=9300, lr=5.24661e-06, gnorm=0.997, loss_scale=1, train_wall=19, wall=2186
2021-01-19 06:06:25 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:06:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:06:26 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:06:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:06:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:06:27 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:06:27 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:06:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:06:30 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:06:30 | INFO | valid | epoch 029 | valid on 'valid' subset | loss 4.163 | nll_loss 2.368 | ppl 5.16 | bleu 38.74 | wps 916.6 | wpb 1083 | bsz 37.8 | num_updates 9389 | best_loss 3.871
2021-01-19 06:06:30 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:06:37 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 29 @ 9389 updates, score 4.163) (writing took 7.351585323922336 seconds)
2021-01-19 06:06:37 | INFO | fairseq_cli.train | end of epoch 29 (average epoch stats below)
2021-01-19 06:06:37 | INFO | train | epoch 029 | loss 2.199 | nll_loss 0.346 | ppl 1.27 | wps 16662.4 | ups 4.34 | wpb 3838.4 | bsz 290.1 | num_updates 9389 | lr 5.22168e-06 | gnorm 0.995 | loss_scale 1 | train_wall 62 | wall 2215
2021-01-19 06:06:37 | INFO | fairseq_cli.train | begin training epoch 29
2021-01-19 06:06:39 | INFO | train_inner | epoch 030:     11 / 324 loss=2.205, nll_loss=0.352, ppl=1.28, wps=12086.2, ups=3.19, wpb=3788.5, bsz=281.5, num_updates=9400, lr=5.21862e-06, gnorm=1.053, loss_scale=1, train_wall=19, wall=2217
2021-01-19 06:06:59 | INFO | train_inner | epoch 030:    111 / 324 loss=2.206, nll_loss=0.353, ppl=1.28, wps=19779, ups=5.18, wpb=3815.3, bsz=288.2, num_updates=9500, lr=5.19109e-06, gnorm=0.995, loss_scale=1, train_wall=19, wall=2236
2021-01-19 06:07:18 | INFO | train_inner | epoch 030:    211 / 324 loss=2.19, nll_loss=0.337, ppl=1.26, wps=20009, ups=5.18, wpb=3861.8, bsz=295, num_updates=9600, lr=5.16398e-06, gnorm=1.018, loss_scale=1, train_wall=19, wall=2256
2021-01-19 06:07:37 | INFO | train_inner | epoch 030:    311 / 324 loss=2.199, nll_loss=0.346, ppl=1.27, wps=19846.6, ups=5.17, wpb=3835.5, bsz=290.6, num_updates=9700, lr=5.13729e-06, gnorm=0.981, loss_scale=1, train_wall=19, wall=2275
2021-01-19 06:07:40 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:07:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:07:40 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:07:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:07:41 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:07:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:07:42 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:07:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:07:44 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:07:44 | INFO | valid | epoch 030 | valid on 'valid' subset | loss 4.171 | nll_loss 2.378 | ppl 5.2 | bleu 38.31 | wps 942.9 | wpb 1083 | bsz 37.8 | num_updates 9713 | best_loss 3.871
2021-01-19 06:07:44 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:07:50 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 30 @ 9713 updates, score 4.171) (writing took 6.023363755084574 seconds)
2021-01-19 06:07:50 | INFO | fairseq_cli.train | end of epoch 30 (average epoch stats below)
2021-01-19 06:07:50 | INFO | train | epoch 030 | loss 2.195 | nll_loss 0.342 | ppl 1.27 | wps 16988.9 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 9713 | lr 5.13385e-06 | gnorm 0.998 | loss_scale 1 | train_wall 62 | wall 2288
2021-01-19 06:07:50 | INFO | fairseq_cli.train | begin training epoch 30
2021-01-19 06:08:07 | INFO | train_inner | epoch 031:     87 / 324 loss=2.173, nll_loss=0.317, ppl=1.25, wps=12835.4, ups=3.34, wpb=3848.4, bsz=290.2, num_updates=9800, lr=5.11101e-06, gnorm=0.893, loss_scale=1, train_wall=19, wall=2305
2021-01-19 06:08:27 | INFO | train_inner | epoch 031:    187 / 324 loss=2.2, nll_loss=0.348, ppl=1.27, wps=19879.9, ups=5.18, wpb=3836.1, bsz=289.6, num_updates=9900, lr=5.08513e-06, gnorm=1, loss_scale=1, train_wall=19, wall=2324
2021-01-19 06:08:46 | INFO | train_inner | epoch 031:    287 / 324 loss=2.196, nll_loss=0.343, ppl=1.27, wps=19864, ups=5.19, wpb=3827.2, bsz=287.7, num_updates=10000, lr=5.05964e-06, gnorm=1.007, loss_scale=1, train_wall=19, wall=2344
2021-01-19 06:08:53 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:08:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:08:54 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:08:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:08:54 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:08:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:08:55 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:08:58 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:08:58 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:08:58 | INFO | valid | epoch 031 | valid on 'valid' subset | loss 4.186 | nll_loss 2.394 | ppl 5.26 | bleu 38.24 | wps 909.3 | wpb 1083 | bsz 37.8 | num_updates 10037 | best_loss 3.871
2021-01-19 06:08:58 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:09:04 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 31 @ 10037 updates, score 4.186) (writing took 5.961319773923606 seconds)
2021-01-19 06:09:04 | INFO | fairseq_cli.train | end of epoch 31 (average epoch stats below)
2021-01-19 06:09:04 | INFO | train | epoch 031 | loss 2.191 | nll_loss 0.338 | ppl 1.26 | wps 16981.6 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 10037 | lr 5.05031e-06 | gnorm 0.989 | loss_scale 1 | train_wall 62 | wall 2361
2021-01-19 06:09:04 | INFO | fairseq_cli.train | begin training epoch 31
2021-01-19 06:09:16 | INFO | train_inner | epoch 032:     63 / 324 loss=2.205, nll_loss=0.35, ppl=1.27, wps=12673, ups=3.34, wpb=3797.6, bsz=280.8, num_updates=10100, lr=5.03453e-06, gnorm=1.12, loss_scale=1, train_wall=19, wall=2374
2021-01-19 06:09:35 | INFO | train_inner | epoch 032:    163 / 324 loss=2.183, nll_loss=0.329, ppl=1.26, wps=19920.1, ups=5.18, wpb=3847.9, bsz=290, num_updates=10200, lr=5.00979e-06, gnorm=0.934, loss_scale=1, train_wall=19, wall=2393
2021-01-19 06:09:54 | INFO | train_inner | epoch 032:    263 / 324 loss=2.181, nll_loss=0.328, ppl=1.26, wps=20032.6, ups=5.16, wpb=3881.9, bsz=297.8, num_updates=10300, lr=4.98542e-06, gnorm=0.96, loss_scale=1, train_wall=19, wall=2412
2021-01-19 06:10:06 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:10:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:10:07 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:10:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:10:08 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:10:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:10:08 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:10:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:10:11 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:10:11 | INFO | valid | epoch 032 | valid on 'valid' subset | loss 4.182 | nll_loss 2.391 | ppl 5.25 | bleu 38.11 | wps 963.4 | wpb 1083 | bsz 37.8 | num_updates 10361 | best_loss 3.871
2021-01-19 06:10:11 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:10:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 32 @ 10361 updates, score 4.182) (writing took 11.980713987722993 seconds)
2021-01-19 06:10:23 | INFO | fairseq_cli.train | end of epoch 32 (average epoch stats below)
2021-01-19 06:10:23 | INFO | train | epoch 032 | loss 2.188 | nll_loss 0.335 | ppl 1.26 | wps 15727.7 | ups 4.1 | wpb 3838.4 | bsz 290.1 | num_updates 10361 | lr 4.97072e-06 | gnorm 0.984 | loss_scale 1 | train_wall 62 | wall 2440
2021-01-19 06:10:23 | INFO | fairseq_cli.train | begin training epoch 32
2021-01-19 06:10:30 | INFO | train_inner | epoch 033:     39 / 324 loss=2.195, nll_loss=0.342, ppl=1.27, wps=10568.6, ups=2.8, wpb=3774.6, bsz=287.8, num_updates=10400, lr=4.96139e-06, gnorm=1.002, loss_scale=1, train_wall=19, wall=2448
2021-01-19 06:10:50 | INFO | train_inner | epoch 033:    139 / 324 loss=2.19, nll_loss=0.337, ppl=1.26, wps=20232.8, ups=5.17, wpb=3910.1, bsz=299.8, num_updates=10500, lr=4.93771e-06, gnorm=0.918, loss_scale=1, train_wall=19, wall=2467
2021-01-19 06:11:09 | INFO | train_inner | epoch 033:    239 / 324 loss=2.183, nll_loss=0.329, ppl=1.26, wps=19784.3, ups=5.19, wpb=3809.1, bsz=288, num_updates=10600, lr=4.91436e-06, gnorm=1.113, loss_scale=1, train_wall=19, wall=2486
2021-01-19 06:11:25 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:11:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:11:26 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:11:27 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:11:27 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:11:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:11:28 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:11:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:11:30 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:11:30 | INFO | valid | epoch 033 | valid on 'valid' subset | loss 4.183 | nll_loss 2.39 | ppl 5.24 | bleu 39.59 | wps 925.5 | wpb 1083 | bsz 37.8 | num_updates 10685 | best_loss 3.871
2021-01-19 06:11:30 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:11:36 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 33 @ 10685 updates, score 4.183) (writing took 6.124014725908637 seconds)
2021-01-19 06:11:36 | INFO | fairseq_cli.train | end of epoch 33 (average epoch stats below)
2021-01-19 06:11:36 | INFO | train | epoch 033 | loss 2.185 | nll_loss 0.33 | ppl 1.26 | wps 16959 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 10685 | lr 4.89477e-06 | gnorm 0.99 | loss_scale 1 | train_wall 62 | wall 2514
2021-01-19 06:11:36 | INFO | fairseq_cli.train | begin training epoch 33
2021-01-19 06:11:39 | INFO | train_inner | epoch 034:     15 / 324 loss=2.177, nll_loss=0.321, ppl=1.25, wps=12769.6, ups=3.32, wpb=3847.4, bsz=288, num_updates=10700, lr=4.89134e-06, gnorm=0.948, loss_scale=1, train_wall=19, wall=2517
2021-01-19 06:11:58 | INFO | train_inner | epoch 034:    115 / 324 loss=2.188, nll_loss=0.335, ppl=1.26, wps=19779.4, ups=5.17, wpb=3824.6, bsz=287.6, num_updates=10800, lr=4.86864e-06, gnorm=0.938, loss_scale=1, train_wall=19, wall=2536
2021-01-19 06:12:18 | INFO | train_inner | epoch 034:    215 / 324 loss=2.169, nll_loss=0.314, ppl=1.24, wps=19907.4, ups=5.17, wpb=3853.5, bsz=293.1, num_updates=10900, lr=4.84626e-06, gnorm=0.968, loss_scale=1, train_wall=19, wall=2555
2021-01-19 06:12:37 | INFO | train_inner | epoch 034:    315 / 324 loss=2.178, nll_loss=0.324, ppl=1.25, wps=19859.7, ups=5.18, wpb=3834.3, bsz=292.5, num_updates=11000, lr=4.82418e-06, gnorm=1.009, loss_scale=1, train_wall=19, wall=2575
2021-01-19 06:12:39 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:12:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:12:39 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:12:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used concomitantly with long-acting insulin products.
2021-01-19 06:12:40 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:12:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:12:41 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:12:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:12:43 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:12:43 | INFO | valid | epoch 034 | valid on 'valid' subset | loss 4.189 | nll_loss 2.401 | ppl 5.28 | bleu 38.91 | wps 930.6 | wpb 1083 | bsz 37.8 | num_updates 11009 | best_loss 3.871
2021-01-19 06:12:43 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:12:48 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 34 @ 11009 updates, score 4.189) (writing took 5.285319522023201 seconds)
2021-01-19 06:12:48 | INFO | fairseq_cli.train | end of epoch 34 (average epoch stats below)
2021-01-19 06:12:48 | INFO | train | epoch 034 | loss 2.182 | nll_loss 0.328 | ppl 1.25 | wps 17157.1 | ups 4.47 | wpb 3838.4 | bsz 290.1 | num_updates 11009 | lr 4.82221e-06 | gnorm 0.982 | loss_scale 1 | train_wall 62 | wall 2586
2021-01-19 06:12:48 | INFO | fairseq_cli.train | begin training epoch 34
2021-01-19 06:13:06 | INFO | train_inner | epoch 035:     91 / 324 loss=2.169, nll_loss=0.314, ppl=1.24, wps=13208.3, ups=3.42, wpb=3861.9, bsz=293.4, num_updates=11100, lr=4.8024e-06, gnorm=0.889, loss_scale=1, train_wall=19, wall=2604
2021-01-19 06:13:25 | INFO | train_inner | epoch 035:    191 / 324 loss=2.191, nll_loss=0.338, ppl=1.26, wps=19897, ups=5.18, wpb=3843.7, bsz=289.5, num_updates=11200, lr=4.78091e-06, gnorm=0.967, loss_scale=1, train_wall=19, wall=2623
2021-01-19 06:13:45 | INFO | train_inner | epoch 035:    291 / 324 loss=2.169, nll_loss=0.314, ppl=1.24, wps=19808.7, ups=5.19, wpb=3817.7, bsz=289.6, num_updates=11300, lr=4.75971e-06, gnorm=0.929, loss_scale=1, train_wall=19, wall=2642
2021-01-19 06:13:51 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:13:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:13:52 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:13:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:13:52 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:13:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:13:53 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:13:56 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:13:56 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:13:56 | INFO | valid | epoch 035 | valid on 'valid' subset | loss 4.188 | nll_loss 2.399 | ppl 5.27 | bleu 39.08 | wps 900.8 | wpb 1083 | bsz 37.8 | num_updates 11333 | best_loss 3.871
2021-01-19 06:13:56 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:14:02 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 35 @ 11333 updates, score 4.188) (writing took 6.31867315992713 seconds)
2021-01-19 06:14:02 | INFO | fairseq_cli.train | end of epoch 35 (average epoch stats below)
2021-01-19 06:14:02 | INFO | train | epoch 035 | loss 2.179 | nll_loss 0.324 | ppl 1.25 | wps 16883.9 | ups 4.4 | wpb 3838.4 | bsz 290.1 | num_updates 11333 | lr 4.75278e-06 | gnorm 0.939 | loss_scale 1 | train_wall 62 | wall 2660
2021-01-19 06:14:02 | INFO | fairseq_cli.train | begin training epoch 35
2021-01-19 06:14:15 | INFO | train_inner | epoch 036:     67 / 324 loss=2.179, nll_loss=0.324, ppl=1.25, wps=12748.3, ups=3.28, wpb=3884.4, bsz=288.2, num_updates=11400, lr=4.73879e-06, gnorm=0.912, loss_scale=1, train_wall=19, wall=2673
2021-01-19 06:14:34 | INFO | train_inner | epoch 036:    167 / 324 loss=2.195, nll_loss=0.341, ppl=1.27, wps=19738.5, ups=5.19, wpb=3800.3, bsz=281.7, num_updates=11500, lr=4.71814e-06, gnorm=1.016, loss_scale=1, train_wall=19, wall=2692
2021-01-19 06:14:54 | INFO | train_inner | epoch 036:    267 / 324 loss=2.169, nll_loss=0.314, ppl=1.24, wps=19746.9, ups=5.17, wpb=3820.2, bsz=292.7, num_updates=11600, lr=4.69776e-06, gnorm=0.907, loss_scale=1, train_wall=19, wall=2712
2021-01-19 06:15:05 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:15:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:15:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:15:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:15:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:15:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:15:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:15:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:15:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:15:09 | INFO | valid | epoch 036 | valid on 'valid' subset | loss 4.224 | nll_loss 2.442 | ppl 5.43 | bleu 39.09 | wps 911 | wpb 1083 | bsz 37.8 | num_updates 11657 | best_loss 3.871
2021-01-19 06:15:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:15:15 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 36 @ 11657 updates, score 4.224) (writing took 5.731284190900624 seconds)
2021-01-19 06:15:15 | INFO | fairseq_cli.train | end of epoch 36 (average epoch stats below)
2021-01-19 06:15:15 | INFO | train | epoch 036 | loss 2.176 | nll_loss 0.321 | ppl 1.25 | wps 17022.3 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 11657 | lr 4.68626e-06 | gnorm 0.914 | loss_scale 1 | train_wall 62 | wall 2733
2021-01-19 06:15:15 | INFO | fairseq_cli.train | begin training epoch 36
2021-01-19 06:15:24 | INFO | train_inner | epoch 037:     43 / 324 loss=2.173, nll_loss=0.318, ppl=1.25, wps=13030, ups=3.36, wpb=3882.9, bsz=293.1, num_updates=11700, lr=4.67764e-06, gnorm=0.853, loss_scale=1, train_wall=19, wall=2741
2021-01-19 06:15:43 | INFO | train_inner | epoch 037:    143 / 324 loss=2.171, nll_loss=0.315, ppl=1.24, wps=19768.7, ups=5.19, wpb=3805.4, bsz=286.7, num_updates=11800, lr=4.65778e-06, gnorm=0.989, loss_scale=1, train_wall=19, wall=2761
2021-01-19 06:16:02 | INFO | train_inner | epoch 037:    243 / 324 loss=2.163, nll_loss=0.308, ppl=1.24, wps=19870.8, ups=5.17, wpb=3845, bsz=295, num_updates=11900, lr=4.63817e-06, gnorm=0.852, loss_scale=1, train_wall=19, wall=2780
2021-01-19 06:16:18 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:16:18 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:16:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:16:19 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:16:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:16:20 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:16:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:16:22 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:16:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:16:22 | INFO | valid | epoch 037 | valid on 'valid' subset | loss 4.238 | nll_loss 2.455 | ppl 5.48 | bleu 38.68 | wps 914.3 | wpb 1083 | bsz 37.8 | num_updates 11981 | best_loss 3.871
2021-01-19 06:16:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:16:28 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 37 @ 11981 updates, score 4.238) (writing took 5.682254844810814 seconds)
2021-01-19 06:16:28 | INFO | fairseq_cli.train | end of epoch 37 (average epoch stats below)
2021-01-19 06:16:28 | INFO | train | epoch 037 | loss 2.174 | nll_loss 0.319 | ppl 1.25 | wps 17039.6 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 11981 | lr 4.62246e-06 | gnorm 0.934 | loss_scale 1 | train_wall 62 | wall 2806
2021-01-19 06:16:28 | INFO | fairseq_cli.train | begin training epoch 37
2021-01-19 06:16:32 | INFO | train_inner | epoch 038:     19 / 324 loss=2.179, nll_loss=0.324, ppl=1.25, wps=12942.2, ups=3.36, wpb=3848.9, bsz=291.7, num_updates=12000, lr=4.6188e-06, gnorm=0.96, loss_scale=1, train_wall=19, wall=2810
2021-01-19 06:16:51 | INFO | train_inner | epoch 038:    119 / 324 loss=2.164, nll_loss=0.308, ppl=1.24, wps=19857.6, ups=5.18, wpb=3832.9, bsz=289.1, num_updates=12100, lr=4.59968e-06, gnorm=0.854, loss_scale=1, train_wall=19, wall=2829
2021-01-19 06:17:10 | INFO | train_inner | epoch 038:    219 / 324 loss=2.193, nll_loss=0.339, ppl=1.26, wps=19822.6, ups=5.19, wpb=3817.1, bsz=284.1, num_updates=12200, lr=4.58079e-06, gnorm=1.017, loss_scale=1, train_wall=19, wall=2848
2021-01-19 06:17:30 | INFO | train_inner | epoch 038:    319 / 324 loss=2.165, nll_loss=0.311, ppl=1.24, wps=19792, ups=5.15, wpb=3841.3, bsz=291.2, num_updates=12300, lr=4.56213e-06, gnorm=1.016, loss_scale=1, train_wall=19, wall=2868
2021-01-19 06:17:31 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:17:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:17:31 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:17:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:17:32 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:17:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:17:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:17:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:17:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:17:35 | INFO | valid | epoch 038 | valid on 'valid' subset | loss 4.227 | nll_loss 2.445 | ppl 5.44 | bleu 38.81 | wps 923.6 | wpb 1083 | bsz 37.8 | num_updates 12305 | best_loss 3.871
2021-01-19 06:17:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:17:41 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 38 @ 12305 updates, score 4.227) (writing took 5.719849082175642 seconds)
2021-01-19 06:17:41 | INFO | fairseq_cli.train | end of epoch 38 (average epoch stats below)
2021-01-19 06:17:41 | INFO | train | epoch 038 | loss 2.171 | nll_loss 0.316 | ppl 1.24 | wps 17027 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 12305 | lr 4.5612e-06 | gnorm 0.947 | loss_scale 1 | train_wall 62 | wall 2879
2021-01-19 06:17:41 | INFO | fairseq_cli.train | begin training epoch 38
2021-01-19 06:18:00 | INFO | train_inner | epoch 039:     95 / 324 loss=2.158, nll_loss=0.302, ppl=1.23, wps=12990.7, ups=3.36, wpb=3864.5, bsz=293, num_updates=12400, lr=4.54369e-06, gnorm=0.867, loss_scale=1, train_wall=19, wall=2897
2021-01-19 06:18:19 | INFO | train_inner | epoch 039:    195 / 324 loss=2.174, nll_loss=0.319, ppl=1.25, wps=19830.1, ups=5.19, wpb=3823.4, bsz=289.2, num_updates=12500, lr=4.52548e-06, gnorm=0.897, loss_scale=1, train_wall=19, wall=2917
2021-01-19 06:18:38 | INFO | train_inner | epoch 039:    295 / 324 loss=2.166, nll_loss=0.313, ppl=1.24, wps=19923.6, ups=5.16, wpb=3863.3, bsz=294.5, num_updates=12600, lr=4.50749e-06, gnorm=0.889, loss_scale=1, train_wall=19, wall=2936
2021-01-19 06:18:44 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:18:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:18:44 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:18:45 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:18:45 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:18:46 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast glycaemic control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:18:46 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:18:48 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:18:48 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:18:48 | INFO | valid | epoch 039 | valid on 'valid' subset | loss 4.215 | nll_loss 2.434 | ppl 5.4 | bleu 39.07 | wps 915.9 | wpb 1083 | bsz 37.8 | num_updates 12629 | best_loss 3.871
2021-01-19 06:18:48 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:18:55 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 39 @ 12629 updates, score 4.215) (writing took 6.941768541000783 seconds)
2021-01-19 06:18:55 | INFO | fairseq_cli.train | end of epoch 39 (average epoch stats below)
2021-01-19 06:18:55 | INFO | train | epoch 039 | loss 2.168 | nll_loss 0.313 | ppl 1.24 | wps 16756 | ups 4.37 | wpb 3838.4 | bsz 290.1 | num_updates 12629 | lr 4.50231e-06 | gnorm 0.891 | loss_scale 1 | train_wall 62 | wall 2953
2021-01-19 06:18:55 | INFO | fairseq_cli.train | begin training epoch 39
2021-01-19 06:19:09 | INFO | train_inner | epoch 040:     71 / 324 loss=2.166, nll_loss=0.31, ppl=1.24, wps=12171.6, ups=3.25, wpb=3748.4, bsz=280.3, num_updates=12700, lr=4.48971e-06, gnorm=0.931, loss_scale=1, train_wall=19, wall=2967
2021-01-19 06:19:29 | INFO | train_inner | epoch 040:    171 / 324 loss=2.15, nll_loss=0.293, ppl=1.23, wps=19976.4, ups=5.16, wpb=3871.2, bsz=296.1, num_updates=12800, lr=4.47214e-06, gnorm=0.864, loss_scale=1, train_wall=19, wall=2986
2021-01-19 06:19:48 | INFO | train_inner | epoch 040:    271 / 324 loss=2.153, nll_loss=0.297, ppl=1.23, wps=20003.8, ups=5.14, wpb=3888.8, bsz=294.8, num_updates=12900, lr=4.45477e-06, gnorm=0.856, loss_scale=1, train_wall=19, wall=3006
2021-01-19 06:19:58 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:19:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:19:59 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:19:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:19:59 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:20:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute painful neuropathy and is usually reversible.
2021-01-19 06:20:00 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:20:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:20:03 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:20:03 | INFO | valid | epoch 040 | valid on 'valid' subset | loss 4.233 | nll_loss 2.454 | ppl 5.48 | bleu 38.84 | wps 887.7 | wpb 1083 | bsz 37.8 | num_updates 12953 | best_loss 3.871
2021-01-19 06:20:03 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:20:09 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 40 @ 12953 updates, score 4.233) (writing took 5.848897768184543 seconds)
2021-01-19 06:20:09 | INFO | fairseq_cli.train | end of epoch 40 (average epoch stats below)
2021-01-19 06:20:09 | INFO | train | epoch 040 | loss 2.166 | nll_loss 0.311 | ppl 1.24 | wps 16972.5 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 12953 | lr 4.44565e-06 | gnorm 0.914 | loss_scale 1 | train_wall 62 | wall 3026
2021-01-19 06:20:09 | INFO | fairseq_cli.train | begin training epoch 40
2021-01-19 06:20:18 | INFO | train_inner | epoch 041:     47 / 324 loss=2.2, nll_loss=0.347, ppl=1.27, wps=12689.5, ups=3.35, wpb=3790.3, bsz=283, num_updates=13000, lr=4.4376e-06, gnorm=0.996, loss_scale=1, train_wall=19, wall=3036
2021-01-19 06:20:37 | INFO | train_inner | epoch 041:    147 / 324 loss=2.159, nll_loss=0.305, ppl=1.24, wps=20050.2, ups=5.15, wpb=3895, bsz=300.4, num_updates=13100, lr=4.42063e-06, gnorm=0.877, loss_scale=1, train_wall=19, wall=3055
2021-01-19 06:20:57 | INFO | train_inner | epoch 041:    247 / 324 loss=2.158, nll_loss=0.302, ppl=1.23, wps=19941.8, ups=5.15, wpb=3870, bsz=287.4, num_updates=13200, lr=4.40386e-06, gnorm=0.847, loss_scale=1, train_wall=19, wall=3074
2021-01-19 06:21:11 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:21:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:21:12 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:21:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:21:13 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:21:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast glycaemic control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:21:14 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:21:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:21:16 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:21:16 | INFO | valid | epoch 041 | valid on 'valid' subset | loss 4.252 | nll_loss 2.477 | ppl 5.57 | bleu 38.73 | wps 900.9 | wpb 1083 | bsz 37.8 | num_updates 13277 | best_loss 3.871
2021-01-19 06:21:16 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:21:22 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 41 @ 13277 updates, score 4.252) (writing took 6.38398668076843 seconds)
2021-01-19 06:21:22 | INFO | fairseq_cli.train | end of epoch 41 (average epoch stats below)
2021-01-19 06:21:22 | INFO | train | epoch 041 | loss 2.164 | nll_loss 0.308 | ppl 1.24 | wps 16862.3 | ups 4.39 | wpb 3838.4 | bsz 290.1 | num_updates 13277 | lr 4.39107e-06 | gnorm 0.889 | loss_scale 1 | train_wall 62 | wall 3100
2021-01-19 06:21:22 | INFO | fairseq_cli.train | begin training epoch 41
2021-01-19 06:21:27 | INFO | train_inner | epoch 042:     23 / 324 loss=2.162, nll_loss=0.306, ppl=1.24, wps=12555.2, ups=3.29, wpb=3811.5, bsz=292.6, num_updates=13300, lr=4.38727e-06, gnorm=0.887, loss_scale=1, train_wall=19, wall=3105
2021-01-19 06:21:46 | INFO | train_inner | epoch 042:    123 / 324 loss=2.164, nll_loss=0.308, ppl=1.24, wps=19686.1, ups=5.18, wpb=3801.8, bsz=287.3, num_updates=13400, lr=4.37087e-06, gnorm=0.914, loss_scale=1, train_wall=19, wall=3124
2021-01-19 06:22:06 | INFO | train_inner | epoch 042:    223 / 324 loss=2.175, nll_loss=0.322, ppl=1.25, wps=19793.1, ups=5.17, wpb=3827.1, bsz=288.9, num_updates=13500, lr=4.35465e-06, gnorm=0.88, loss_scale=1, train_wall=19, wall=3143
2021-01-19 06:22:25 | INFO | train_inner | epoch 042:    323 / 324 loss=2.157, nll_loss=0.299, ppl=1.23, wps=19863.7, ups=5.14, wpb=3862.3, bsz=287.7, num_updates=13600, lr=4.33861e-06, gnorm=0.87, loss_scale=1, train_wall=19, wall=3163
2021-01-19 06:22:25 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:22:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:22:26 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:22:27 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:22:27 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:22:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:22:28 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:22:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:22:30 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:22:30 | INFO | valid | epoch 042 | valid on 'valid' subset | loss 4.268 | nll_loss 2.494 | ppl 5.63 | bleu 39.6 | wps 899.3 | wpb 1083 | bsz 37.8 | num_updates 13601 | best_loss 3.871
2021-01-19 06:22:30 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:22:36 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 42 @ 13601 updates, score 4.268) (writing took 5.741951353382319 seconds)
2021-01-19 06:22:36 | INFO | fairseq_cli.train | end of epoch 42 (average epoch stats below)
2021-01-19 06:22:36 | INFO | train | epoch 042 | loss 2.162 | nll_loss 0.307 | ppl 1.24 | wps 16973.4 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 13601 | lr 4.33845e-06 | gnorm 0.889 | loss_scale 1 | train_wall 62 | wall 3173
2021-01-19 06:22:36 | INFO | fairseq_cli.train | begin training epoch 42
2021-01-19 06:22:55 | INFO | train_inner | epoch 043:     99 / 324 loss=2.166, nll_loss=0.309, ppl=1.24, wps=12688.8, ups=3.36, wpb=3774.7, bsz=285, num_updates=13700, lr=4.32275e-06, gnorm=0.959, loss_scale=1, train_wall=19, wall=3193
2021-01-19 06:23:14 | INFO | train_inner | epoch 043:    199 / 324 loss=2.162, nll_loss=0.305, ppl=1.24, wps=19832.1, ups=5.17, wpb=3833.5, bsz=281.5, num_updates=13800, lr=4.30706e-06, gnorm=0.983, loss_scale=1, train_wall=19, wall=3212
2021-01-19 06:23:34 | INFO | train_inner | epoch 043:    299 / 324 loss=2.156, nll_loss=0.303, ppl=1.23, wps=20119.2, ups=5.17, wpb=3892.2, bsz=302.9, num_updates=13900, lr=4.29153e-06, gnorm=0.859, loss_scale=1, train_wall=19, wall=3231
2021-01-19 06:23:38 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:23:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:23:39 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:23:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:23:40 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:23:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:23:41 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:23:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:23:43 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:23:43 | INFO | valid | epoch 043 | valid on 'valid' subset | loss 4.269 | nll_loss 2.498 | ppl 5.65 | bleu 39.22 | wps 914.2 | wpb 1083 | bsz 37.8 | num_updates 13925 | best_loss 3.871
2021-01-19 06:23:43 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:23:49 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 43 @ 13925 updates, score 4.269) (writing took 5.733154522720724 seconds)
2021-01-19 06:23:49 | INFO | fairseq_cli.train | end of epoch 43 (average epoch stats below)
2021-01-19 06:23:49 | INFO | train | epoch 043 | loss 2.16 | nll_loss 0.305 | ppl 1.24 | wps 17029 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 13925 | lr 4.28768e-06 | gnorm 0.909 | loss_scale 1 | train_wall 62 | wall 3246
2021-01-19 06:23:49 | INFO | fairseq_cli.train | begin training epoch 43
2021-01-19 06:24:03 | INFO | train_inner | epoch 044:     75 / 324 loss=2.168, nll_loss=0.312, ppl=1.24, wps=12863.3, ups=3.36, wpb=3824.6, bsz=284, num_updates=14000, lr=4.27618e-06, gnorm=1.009, loss_scale=1, train_wall=19, wall=3261
2021-01-19 06:24:23 | INFO | train_inner | epoch 044:    175 / 324 loss=2.141, nll_loss=0.283, ppl=1.22, wps=19892.5, ups=5.17, wpb=3851, bsz=292, num_updates=14100, lr=4.26099e-06, gnorm=0.798, loss_scale=1, train_wall=19, wall=3280
2021-01-19 06:24:42 | INFO | train_inner | epoch 044:    275 / 324 loss=2.166, nll_loss=0.311, ppl=1.24, wps=19879.7, ups=5.18, wpb=3838.2, bsz=291.1, num_updates=14200, lr=4.24596e-06, gnorm=0.862, loss_scale=1, train_wall=19, wall=3300
2021-01-19 06:24:51 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:24:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:24:52 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:24:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:24:53 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:24:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:24:54 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:24:56 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial of 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:24:56 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:24:56 | INFO | valid | epoch 044 | valid on 'valid' subset | loss 4.279 | nll_loss 2.509 | ppl 5.69 | bleu 39.73 | wps 912 | wpb 1083 | bsz 37.8 | num_updates 14249 | best_loss 3.871
2021-01-19 06:24:56 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:25:02 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 44 @ 14249 updates, score 4.279) (writing took 5.915243736933917 seconds)
2021-01-19 06:25:02 | INFO | fairseq_cli.train | end of epoch 44 (average epoch stats below)
2021-01-19 06:25:02 | INFO | train | epoch 044 | loss 2.158 | nll_loss 0.302 | ppl 1.23 | wps 16990.7 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 14249 | lr 4.23865e-06 | gnorm 0.884 | loss_scale 1 | train_wall 62 | wall 3320
2021-01-19 06:25:02 | INFO | fairseq_cli.train | begin training epoch 44
2021-01-19 06:25:12 | INFO | train_inner | epoch 045:     51 / 324 loss=2.148, nll_loss=0.293, ppl=1.23, wps=12848.4, ups=3.34, wpb=3844.4, bsz=299.8, num_updates=14300, lr=4.23109e-06, gnorm=0.823, loss_scale=1, train_wall=19, wall=3330
2021-01-19 06:25:31 | INFO | train_inner | epoch 045:    151 / 324 loss=2.147, nll_loss=0.289, ppl=1.22, wps=19645.2, ups=5.18, wpb=3790.2, bsz=279.1, num_updates=14400, lr=4.21637e-06, gnorm=0.89, loss_scale=1, train_wall=19, wall=3349
2021-01-19 06:25:51 | INFO | train_inner | epoch 045:    251 / 324 loss=2.163, nll_loss=0.309, ppl=1.24, wps=20011, ups=5.16, wpb=3881.8, bsz=294.9, num_updates=14500, lr=4.20181e-06, gnorm=0.848, loss_scale=1, train_wall=19, wall=3368
2021-01-19 06:26:05 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:26:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:26:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:26:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:26:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:26:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast glycaemic control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:26:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:26:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in type 1 diabetes patients in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in type 2 diabetes patients in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:26:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:26:09 | INFO | valid | epoch 045 | valid on 'valid' subset | loss 4.282 | nll_loss 2.513 | ppl 5.71 | bleu 39.48 | wps 933.9 | wpb 1083 | bsz 37.8 | num_updates 14573 | best_loss 3.871
2021-01-19 06:26:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:26:16 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 45 @ 14573 updates, score 4.282) (writing took 6.742004093714058 seconds)
2021-01-19 06:26:16 | INFO | fairseq_cli.train | end of epoch 45 (average epoch stats below)
2021-01-19 06:26:16 | INFO | train | epoch 045 | loss 2.156 | nll_loss 0.3 | ppl 1.23 | wps 16809.6 | ups 4.38 | wpb 3838.4 | bsz 290.1 | num_updates 14573 | lr 4.19127e-06 | gnorm 0.858 | loss_scale 1 | train_wall 62 | wall 3394
2021-01-19 06:26:16 | INFO | fairseq_cli.train | begin training epoch 45
2021-01-19 06:26:21 | INFO | train_inner | epoch 046:     27 / 324 loss=2.159, nll_loss=0.301, ppl=1.23, wps=12444.4, ups=3.26, wpb=3817.2, bsz=285, num_updates=14600, lr=4.18739e-06, gnorm=0.838, loss_scale=1, train_wall=19, wall=3399
2021-01-19 06:26:41 | INFO | train_inner | epoch 046:    127 / 324 loss=2.15, nll_loss=0.295, ppl=1.23, wps=19970.2, ups=5.16, wpb=3870.6, bsz=293.1, num_updates=14700, lr=4.17312e-06, gnorm=0.883, loss_scale=1, train_wall=19, wall=3418
2021-01-19 06:27:00 | INFO | train_inner | epoch 046:    227 / 324 loss=2.169, nll_loss=0.314, ppl=1.24, wps=19776.2, ups=5.21, wpb=3793.4, bsz=284.1, num_updates=14800, lr=4.159e-06, gnorm=0.903, loss_scale=1, train_wall=19, wall=3438
2021-01-19 06:27:19 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:27:19 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:27:19 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:27:20 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:27:20 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:27:21 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast glycaemic control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:27:21 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:27:23 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:27:23 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:27:23 | INFO | valid | epoch 046 | valid on 'valid' subset | loss 4.312 | nll_loss 2.549 | ppl 5.85 | bleu 38.89 | wps 924 | wpb 1083 | bsz 37.8 | num_updates 14897 | best_loss 3.871
2021-01-19 06:27:23 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:27:29 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 46 @ 14897 updates, score 4.312) (writing took 5.686845355667174 seconds)
2021-01-19 06:27:29 | INFO | fairseq_cli.train | end of epoch 46 (average epoch stats below)
2021-01-19 06:27:29 | INFO | train | epoch 046 | loss 2.154 | nll_loss 0.298 | ppl 1.23 | wps 17053.3 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 14897 | lr 4.14544e-06 | gnorm 0.85 | loss_scale 1 | train_wall 62 | wall 3467
2021-01-19 06:27:29 | INFO | fairseq_cli.train | begin training epoch 46
2021-01-19 06:27:29 | INFO | train_inner | epoch 047:      3 / 324 loss=2.15, nll_loss=0.294, ppl=1.23, wps=13070.5, ups=3.37, wpb=3883.3, bsz=296.9, num_updates=14900, lr=4.14502e-06, gnorm=0.78, loss_scale=1, train_wall=19, wall=3467
2021-01-19 06:27:49 | INFO | train_inner | epoch 047:    103 / 324 loss=2.152, nll_loss=0.295, ppl=1.23, wps=19703.8, ups=5.19, wpb=3794.3, bsz=284.2, num_updates=15000, lr=4.13118e-06, gnorm=0.843, loss_scale=1, train_wall=19, wall=3486
2021-01-19 06:28:08 | INFO | train_inner | epoch 047:    203 / 324 loss=2.156, nll_loss=0.302, ppl=1.23, wps=19956.3, ups=5.16, wpb=3865.9, bsz=292.6, num_updates=15100, lr=4.11748e-06, gnorm=0.806, loss_scale=1, train_wall=19, wall=3506
2021-01-19 06:28:27 | INFO | train_inner | epoch 047:    303 / 324 loss=2.15, nll_loss=0.294, ppl=1.23, wps=19915.1, ups=5.18, wpb=3843.4, bsz=294.1, num_updates=15200, lr=4.10391e-06, gnorm=0.838, loss_scale=1, train_wall=19, wall=3525
2021-01-19 06:28:32 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:28:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:28:32 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:28:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:28:33 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:28:34 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast glycaemic control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:28:34 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:28:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:28:36 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:28:36 | INFO | valid | epoch 047 | valid on 'valid' subset | loss 4.309 | nll_loss 2.542 | ppl 5.82 | bleu 39.04 | wps 941.1 | wpb 1083 | bsz 37.8 | num_updates 15221 | best_loss 3.871
2021-01-19 06:28:36 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:28:43 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 47 @ 15221 updates, score 4.309) (writing took 6.9593767137266695 seconds)
2021-01-19 06:28:43 | INFO | fairseq_cli.train | end of epoch 47 (average epoch stats below)
2021-01-19 06:28:43 | INFO | train | epoch 047 | loss 2.152 | nll_loss 0.296 | ppl 1.23 | wps 16778.7 | ups 4.37 | wpb 3838.4 | bsz 290.1 | num_updates 15221 | lr 4.10108e-06 | gnorm 0.821 | loss_scale 1 | train_wall 62 | wall 3541
2021-01-19 06:28:43 | INFO | fairseq_cli.train | begin training epoch 47
2021-01-19 06:28:58 | INFO | train_inner | epoch 048:     79 / 324 loss=2.157, nll_loss=0.302, ppl=1.23, wps=12414.5, ups=3.25, wpb=3821.2, bsz=288.6, num_updates=15300, lr=4.09048e-06, gnorm=0.835, loss_scale=1, train_wall=19, wall=3556
2021-01-19 06:29:18 | INFO | train_inner | epoch 048:    179 / 324 loss=2.143, nll_loss=0.286, ppl=1.22, wps=19746.1, ups=5.16, wpb=3825.1, bsz=288, num_updates=15400, lr=4.07718e-06, gnorm=0.875, loss_scale=1, train_wall=19, wall=3575
2021-01-19 06:29:37 | INFO | train_inner | epoch 048:    279 / 324 loss=2.143, nll_loss=0.287, ppl=1.22, wps=19899, ups=5.15, wpb=3861.9, bsz=296.3, num_updates=15500, lr=4.064e-06, gnorm=0.878, loss_scale=1, train_wall=19, wall=3595
2021-01-19 06:29:46 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:29:46 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:29:46 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:29:47 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:29:47 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:29:48 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast glycaemic control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:29:48 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:29:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial of 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:29:50 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:29:50 | INFO | valid | epoch 048 | valid on 'valid' subset | loss 4.308 | nll_loss 2.54 | ppl 5.82 | bleu 39.29 | wps 919.8 | wpb 1083 | bsz 37.8 | num_updates 15545 | best_loss 3.871
2021-01-19 06:29:50 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:29:56 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 48 @ 15545 updates, score 4.308) (writing took 5.741038121283054 seconds)
2021-01-19 06:29:56 | INFO | fairseq_cli.train | end of epoch 48 (average epoch stats below)
2021-01-19 06:29:56 | INFO | train | epoch 048 | loss 2.151 | nll_loss 0.295 | ppl 1.23 | wps 17020.6 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 15545 | lr 4.05812e-06 | gnorm 0.88 | loss_scale 1 | train_wall 62 | wall 3614
2021-01-19 06:29:56 | INFO | fairseq_cli.train | begin training epoch 48
2021-01-19 06:30:07 | INFO | train_inner | epoch 049:     55 / 324 loss=2.16, nll_loss=0.305, ppl=1.24, wps=12850.7, ups=3.37, wpb=3810.1, bsz=286.2, num_updates=15600, lr=4.05096e-06, gnorm=0.915, loss_scale=1, train_wall=19, wall=3624
2021-01-19 06:30:26 | INFO | train_inner | epoch 049:    155 / 324 loss=2.145, nll_loss=0.289, ppl=1.22, wps=19917.2, ups=5.15, wpb=3864.2, bsz=294.2, num_updates=15700, lr=4.03804e-06, gnorm=0.897, loss_scale=1, train_wall=19, wall=3644
2021-01-19 06:30:45 | INFO | train_inner | epoch 049:    255 / 324 loss=2.156, nll_loss=0.299, ppl=1.23, wps=19781.9, ups=5.19, wpb=3812.9, bsz=283.1, num_updates=15800, lr=4.02524e-06, gnorm=0.893, loss_scale=1, train_wall=19, wall=3663
2021-01-19 06:30:59 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:30:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:30:59 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:31:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:31:00 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:31:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:31:01 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:31:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial of 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:31:03 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:31:03 | INFO | valid | epoch 049 | valid on 'valid' subset | loss 4.316 | nll_loss 2.553 | ppl 5.87 | bleu 39.53 | wps 900.9 | wpb 1083 | bsz 37.8 | num_updates 15869 | best_loss 3.871
2021-01-19 06:31:03 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:31:09 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 49 @ 15869 updates, score 4.316) (writing took 5.872659062035382 seconds)
2021-01-19 06:31:09 | INFO | fairseq_cli.train | end of epoch 49 (average epoch stats below)
2021-01-19 06:31:09 | INFO | train | epoch 049 | loss 2.149 | nll_loss 0.292 | ppl 1.22 | wps 16980.1 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 15869 | lr 4.01648e-06 | gnorm 0.871 | loss_scale 1 | train_wall 62 | wall 3687
2021-01-19 06:31:09 | INFO | fairseq_cli.train | begin training epoch 49
2021-01-19 06:31:15 | INFO | train_inner | epoch 050:     31 / 324 loss=2.144, nll_loss=0.287, ppl=1.22, wps=12910.9, ups=3.33, wpb=3876.8, bsz=290.8, num_updates=15900, lr=4.01256e-06, gnorm=0.788, loss_scale=1, train_wall=19, wall=3693
2021-01-19 06:31:35 | INFO | train_inner | epoch 050:    131 / 324 loss=2.151, nll_loss=0.296, ppl=1.23, wps=20047.8, ups=5.16, wpb=3885.4, bsz=298.9, num_updates=16000, lr=4e-06, gnorm=0.813, loss_scale=1, train_wall=19, wall=3712
2021-01-19 06:31:54 | INFO | train_inner | epoch 050:    231 / 324 loss=2.141, nll_loss=0.283, ppl=1.22, wps=19605.6, ups=5.18, wpb=3784.7, bsz=281.6, num_updates=16100, lr=3.98756e-06, gnorm=0.812, loss_scale=1, train_wall=19, wall=3732
2021-01-19 06:32:12 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:32:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 06:32:12 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:32:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:32:13 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:32:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast glycaemic control may be associated with discomfort known as acute pain neuropathy and is usually reversible.
2021-01-19 06:32:14 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:32:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes in whom the pancreas cannot produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in whom the body cannot effectively process insulin (a trial of 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring for six months the concentration in blood of a substance called glycosylated haemoglobin (HbA1c) that indicates how well blood glucose is controlled UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP What benefit has Actrapide shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remain relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:32:17 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:32:17 | INFO | valid | epoch 050 | valid on 'valid' subset | loss 4.321 | nll_loss 2.557 | ppl 5.88 | bleu 38.59 | wps 897 | wpb 1083 | bsz 37.8 | num_updates 16193 | best_loss 3.871
2021-01-19 06:32:17 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:32:22 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_6/checkpoint_last.pt (epoch 50 @ 16193 updates, score 4.321) (writing took 5.792260223068297 seconds)
2021-01-19 06:32:22 | INFO | fairseq_cli.train | end of epoch 50 (average epoch stats below)
2021-01-19 06:32:22 | INFO | train | epoch 050 | loss 2.147 | nll_loss 0.291 | ppl 1.22 | wps 17007.2 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 16193 | lr 3.97609e-06 | gnorm 0.816 | loss_scale 1 | train_wall 62 | wall 3760
2021-01-19 06:32:22 | INFO | fairseq_cli.train | done training in 3750.1 seconds


###############################################################################
Peregrine Cluster
Job 17437247 for user 's3475743'
Finished at: Tue Jan 19 06:32:27 CET 2021

Job details:
============

Job ID              : 17437247
Name                : EMEA_p_6
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu27
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-01-19T04:41:48
Start               : 2021-01-19T05:29:03
End                 : 2021-01-19T06:32:27
Reserved walltime   : 23:55:00
Used walltime       : 01:03:24
Used CPU time       : 01:08:14 (efficiency:  8.97%)
% User (Computation): 68.63%
% System (I/O)      : 31.37%
Mem reserved        : 32G/node
Max Mem used        : 5.60G (pg-gpu27)
Max Disk Write      : 40.96K (pg-gpu27)
Max Disk Read       : 2.30M (pg-gpu27)
Average GPU usage   : 80.6% (pg-gpu27)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/introduction/scientific_output

################################################################################
